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Zusammenfassung 
Fettleibigkeit hat sich zu einem weltweiten Gesundheitsproblem in der Öffentlichkeit 
entwickelt. Sie wird durch ein komplexes Ungleichgewicht der Regulation von Appetit und 
Energiestoffwechsel verursacht, die durch verschiedene Faktoren wie genetische Defekte, 
Nahrungspräferenzen und Lebensstil kontrolliert werden. Die hochfetthaltige westliche 
Nahrung ist einer Hauptfaktor, die die Entwicklung von Fettleibigkeit in der menschlichen 
Bevölkerung fördert. Trotzdem werden nicht alle Konsumenten der Hochfettnahrung fettleibig. 
In dieser Studie wurden zwei unterschiedliche Mausinzuchtlinien – AKR/J und SWR/J – 
entweder mit einer hoch fetthaltigen Nahrung oder der Standardnahrung gefüttert. Der AKR/J 
Stamm repräsentiert ein Mausmodel für diät-induzierte Fettleibigkeit (diet-induced obesity = 
DIO). Mäuse dieses Stammes wurden fett wenn sie mit der hochfetthaltigen Diät gefüttert 
wurden, wohingegen sie schlank bei Fütterung mit der Standard-Diät blieben. Im Gegensatz 
dazu waren die Mäuse des SWR/J Stamm resistent gegenüber der DIO, d.h. es war im 
Vergleich kein wahrnehmbar Anstieg des Körpergewichts oder von Fettleibigkeit in Mäusen, 
die mit fetthaltiger Nahrung oder Standard-Diät gefüttert wurden. Genexpressions-Arrays 
wurden benutzt um differentiell exprimierte Gene im Hypothalamus von AKR/J und SWR/J 
Mäusen bei fetthaltiger Fütterung zu identifizieren. Um die Kandidatengene, ausgesucht aus der 
Array Datenanalyse to validieren, wurde Northern Blot Analyse, in situ Hybridisierung und 
real-time RT-PCR durchgeführt.  
Hämoglobin alpha, adult chain 1 (Hba-α1) ist auf dem Chromosom 11 der Maus (Chromosom 
16p13.3 des Menschen) lokalisiert. Die funktionelle Bedeutung der Expression von Hba-α1 ist 
unbekannt. Eventuell erleichtert es den Sauerstofftransport im Gehirn in einer ähnlichen Weise 
wie das Myoglobin im Skelettmuskel. In dieser Arbeit wurde eine höhere ubiquitäre Expression 
von  Hba-α1 im Hirn der SWR/J Maus im Vergleich zur AKR/J Maus beobachtet. Dieser 
Unterschied könnte mit der höheren Stoffwechselrate der SWR/J Mäuse zusammenhängen. So 
weit konnte keine direkte Beziehung zwischen Hba-α1 Expression und Fettleibigkeit hergestellt 
werden. 
Im Gegensatz dazu zeigt die Glyoxalase I (Glo 1) ein spezifisches Expressionsmuster mit 
stärkster Präsenz im Hippocampus. Im Hypothalamus kann die Glo1 Expression im 
arquatischen Nukleus (ARC), im ventromedialen hypothalamischen Nukleus (VMH) und im 
paraventricularen hypothalamischen Nukleus (PVN) detektiert werden. Während die 
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Expression von Glo1 ausserhalb des Hypothalamus ähnlich in beiden Mausstämmen ist, ist die 
mRNA Expression in der hypothalamischen Region viel stärker in AKR/J im Vergleich zur 
SWR/J Mäusen. Das Glo1 Gen befindet sich auf Chromosom 17 der Maus (Chr. 6 des 
Menschen) und an der Entgiftung von Stoffwechselnebenprodukten beteiligt. Außerdem wurde 
Glo1 auf der Fettleibigkeits-Genkarte vom Menschen verzeichnet und vermutet eine 
Verbindung zwischen einer abweichenden Expression des Glyoxalase-Systems und 
Krankheiten wie Krebs und Diabetes. 
Tumor Nekrose Faktor alpha-induziertes Protein 1 (endothelial) (tumor necrosis factor alpha 
induced protein 1 (TNFAIP1) ist auf Maus-Chromosom 11(45,10 cM) und Mensch-
Chromosom 17q22-q23 lokalisiert. Das Protein ist beim Kalium-Eisen-Transport durch 
Proteinbindung und bei der Einstellung der spannungsabhängigen Kaliumkanal Aktivitäten 
involviert. TNFAIP1 lokalisiert sich im ARC, im VMH und PVN. Es wurde durch Hochfett-
Diäten in den AKR/J aber nicht SWR/J Mäusen hochreguliert, was an den Filterarrays und den 
Northern Blots, aber nicht mit der real-time RT-PCR und in situ Hybridisierungen gezeigt 
werden konnte. Obwohl bei der in situ Hybridisierung eine 1,6fache Steigerung der mRNA 
Expression im ARC und VMH durch die Hochfettdiät beobachtet werden konnte, war diese 
Steigerung aufgrund individueller Variationen nicht signifikant. Weitere Experimente mit 
höherer Stichprobenzahl müssten durchgeführt werden um dieses Ergebnis zu bestätigen. Weil 
es sich um ein neu annotiertes Gen handelt, ist nicht viel über die pathologische Relevanz 
bekannt. Bisher hat keine Studie eine Verbindung zwischen TNFAIP1 und Fettleibigkeit 
beschrieben. Es wird angenommen, dass TNFα einen Einfluss auf Körpergewichtsregulation 
hat und wahrscheinlich durch einen lokalen Prozess im Fettgewebe wirkt. Möglicherweise führt 
eine erhöhte Sekretion von TNFα aus Adipozyten in fettleibigen Versuchstieren/-personen zu 
einer Induktion von TNFAIP1 im Hypothalamus. Weitere Studien sollten durchgeführt werden 
um die Funktion von TNFAIP1 im Gehirn aufzuklären.   
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1 Summary   
Obesity has developed to a worldwide public health problem. It is caused by a complex 
disorder of appetite regulation and energy metabolism which are controlled by multiple factors 
such as genetic predisposition, dietary preferences and life style. The high-fat western-type diet 
is one of the major factors promoting the development of obesity in the human population. 
However, not all of the high-fat diet consumers become obese. 
In this study, two different inbred mouse strains – AKR/J and SWR/J were either fed a high-fat 
diet or standard chow diet. The AKR/J strain represents a mouse model for diet-induced obesity 
(DIO). Mice of this strain developed obesity when fed a high fat diet, whereas they remained 
lean on a standard chow. In contrast, mice of the SWR/J strain are resistant to DIO, i.e., there 
was no discernable increase in body weight or adiposity in mice fed a high fat diet as compared 
to standard chow. The gene expression arrays were applied to identify differentially expressed 
genes in the hypothalamus of AKR/J and SWR/J mice in response to high-fat diet feeding. For 
the candidate genes selected from array data analysis, validation was carried out by northern 
blot analysis, in situ hybridization and real-time PCR.  
Hemoglobin alpha, adult chain 1 (Hba-α1) is located on mouse chromosome 11 (human 
chromosome 16p13.3). The functional significance of Hba-α1 expression is unclear. Perhaps it 
facilitates oxygen transport in the brain in a similar manner as myoglobin in muscle. In this 
study, overall the expression of Hba-α1 in brain was higher in SWR/J compared to AKR/J 
mice. This difference between strains may be related to the fact that SWR/J mice have a higher 
metabolic rate. So far, no direct relationship between Hba-α1 expression and obesity has been 
suggested. 
In contrast, Glyoxalase I (Glo 1) shows a very distinct expression pattern with highest levels 
found in the hippocampus. In the hypothalamus, Glo1 expression can be found in the arcuate 
nucleus (ARC), ventromedial hypothalamic nucleus (VMH) and paraventricular hypothalamic 
nucleus (PVN). Whereas the expression of Glo1 outside the hypothalamus is similar in both 
strains, Glo1 mRNA expression within the hypothalamic region is much stronger in AKR/J 
compared to SWR/J mice. Glo 1 is located on mouse chromosome 17 (human chromosome 6) 
and involved in the detoxification of metabolic by-products. It was assigned to the human 
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obesity gene map and has been suggested that aberrant expression of the glyoxalase system is 
related to cancer and diabetes. 
Tumor necrosis factor alpha-induced protein 1 (endothelial) (TNFAIP1) is on mouse 
chromosome 11 (45.10 cM) and human 17q22-q23. The protein functions in potassium ion 
transport by protein binding and voltage-gated potassium channel activity adjustment. 
TNFAIP1 localizes in the ARC, the VMH and PVN. It was upregulated by high fat diet in 
AKR/J mice but not in SWR/J mice, which was shown in filter array and Northern blot but not 
in real-time RT-PCR and in situ hybridization. In the in situ hybridization, although it showed 
1.6 fold upregulation in the ARC and VMH by high fat diet, this difference was not significant 
because of the individual variation, further experiment with more samples should be carried out 
to confirm this conclusion. Because it is a newly assigned gene not much information on its 
pathological relevance is available. So far, there have been no papers linking TNFAIP1 and 
obesity. However, many publications report on a role of TNFα in obesity. It is believed that 
TNFα has an effect on body weight regulation and that it acts probably through a local action 
on adipose tissue. Possibly, elevated secretion of TNFα from adipocytes in obese subjects leads 
to induction of TNFAIP1 in the hypothalamus. Further research needs to be conducted to 
elucidate the function of TNFAIP1 in the brain.  
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2 Introduction 
The word obesity is derived from the Latin – ob, means “on account of”, and esito, means “to 
keep eating”. Obesity is defined by the WHO as a body mass index (BMI) > 30 kg/m2 
(1995;Garrow & Webster, 1985), where BMI is calculated by dividing a person's body weight 
in kilograms by his or her height in meters squared (weight [kg] / height [m2]).  
 
2.1 Epidemiology of obesity 
The prevalence of obesity has increased markedly over the past few decades (1960s). The 
WHO has described obesity as the major unmet public health problem worldwide (2000). From 
1995 to 2000, the number of obese adults has increased from about 200 million to over 300 
million in the world (www.who.int). During the past 20 years there has been a dramatic 
increase in obesity in the United States (Figure 1.1). In 1991, four states reported adult obesity 
prevalence rates of 15–19 percent and no states reported rates at or above 20 percent. In 2002, 
15 states had obesity prevalence rates of 15–19 percent; 31 states had rates of 20–24 percent; 
and 4 state reported a rate over 25 percent (Behavioral Risk Factor Surveillance System 
(BRFSS), CDC www.cdc.gov).  
 
 
 
 
 
 
Figure 1.1 Obesity trends (BMI ≥ 30) among U.S. adults in 1991 1995 and 2002.  
 
The data derived from the third National Health and Nutrition Examination Surveys (NHANES 
III) showed that 56% of adults were overweight (BMI ≥ 25) and nearly a quarter (23%) were 
obese (Flegal et al., 1998). The data from the 1999-2000 NHANES show almost 65% of the 
adult population in the United States is overweight and 31% is obese (www.cdc.gov) (Flegal et 
al., 2002). For the clinically severe obesity (BMI ≥ 45), Sturm reported that from 1986 to 2000 
19951991 2003
No Data           <10%              10%–14% 15%–19%           20%–24% ≥25%
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the prevalence of a BMI ≥ 40 in adult Americans quadrupled from 1 in 200 to 1 in 20 and that 
of a BMI ≥ 50 from 1 in 2000 to 1 in 400 (Sturm, 2003). 
In Europe, more than half the adult population between 35 and 65 years of age were either 
overweight or obese (Kopelman, 2000). The data from International Obesity Task Force (IOTF, 
http://www.iotf.org) suggest that the range of obesity prevalence in European countries is from 
10 to 20% for men, and 10 to 25% for women. In Germany, 50% of the adult population are 
overweight and 20% are obese (Heseker & Schmid, 2000). Among German school children (7-
14 years old), the prevalence of overweight increased between 1975 and 1995 from 10.0 to 
16.3% in boys and from 11.7 to 20.7% in girls (Kromeyer-Hauschild et al., 1999). For the pre-
school children (5-6 years of age), in 1982, 8.5% of all children were overweight and 1.8% 
were obese; in contrast in 1997 12.3% were overweight and 2.8% were obese (Kalies et al., 
2002).  
Although it is widely acknowledged that obesity has emerged as an epidemic in the recent two 
to three decades in developed countries, it is not just a disease there. Popkin et al. collected the 
data from different countries and reported that adult obesity levels in developing countries are 
as high as or even higher than those reported for the United States and other developed 
countries, and are increasing rapidly (Popkin & Doak, 1998). In China, the prevalence of 
overweight individuals doubled in women (10.4 to 20.8%) and almost tripled in men (5.0 to 
14.1%) from 1989 to 1997 (Bell et al., 2001). In developing countries this problem does not 
emerge only in adults but also in children and adolescents (Popkin et al., 1996;Wang et al., 
2002). 
 
2.2 Effects of obesity  
Obesity is not just a matter of being obese but it has also dramatic effect on health. Obesity is 
an important risk factor for a range of chronic disease conditions, for instance, cardiovascular 
disease (Pi-Sunyer, 1993;Wilson & Kannel, 2002), type II diabetes (non insulin dependent 
diabetes mellitus, NIDDM) (Chan et al., 1994;Colditz et al., 1995), and hypertension (Cassano 
et al., 1990;Huang et al., 1998;Stamler et al., 1978).  Overweight and obesity were significantly 
associated with some kinds of cancer, gallbladder disease and musculoskeletal disorders (Pi-
Sunyer, 1993), high cholesterol, asthma, arthritis, and poor health status (Mokdad et al., 2003).  
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About 300,000 U.S. deaths a year are associated with obesity and overweight, compared to 
more than 400,000 deaths a year associated with smoking (McGinnis & Foege, 1993) 
(www.surgeongeneral.gov). In the EU, Banegas et al. reported that a minimum of 279,000 
deaths were attributable to excess weight (Banegas et al., 2003).  
The economic effect of obesity in the United States is estimated at approximately 6% of the 
national health expenditure and costs of care. The number of physician visits related to obesity 
has increased 88% in a 6-year period (from 1988 to 1994) (Wolf, 1998). In the United States, 
the total direct and indirect costs attributed to overweight and obesity amounted to $117 billion 
(€91 billion) in the year 2000 (2001) (www.surgeongeneral.gov). The total costs to European 
society are between €70 and €135 billion a year (Rayner & Rayner, 2003). In Germany obesity 
and the obesity-related morbidity and mortality caused costs of nearly 20.7 billion DM (€10.6 
billion) in 1995 (Heseker & Schmid, 2000). The direct cost of obesity to the NHS (National 
Health Service, UK) is £0.5 billion (€0.7 billion), while the indirect cost to the UK economy is 
at least £2 billion (€2.8 billion) (Vlad, 2003).  
 
2.3 Etiology  
Obesity is not a single disorder but a heterogeneous group of conditions with multiple causes. 
Obesity involves complex etiological interactions between the genetic, metabolic and neural 
frameworks on one hand and behavior, food habits, physical activity and socio-cultural factors 
on the other. 
 
2.3.1 External factors 
Energy balance and body composition depend upon energy intake and expenditure (Martinez & 
Fruhbeck, 1996;Friedman, 2000), which appears to be under control on an axis with three 
components: food intake; fuel utilization and thermogenesis; and adipocyte metabolism.The 
main reason for the current obesity epidemic is a changing environment that promotes 
excessive food (calorie) intake and discourages physical activity (Hill & Peters, 1998;Hill et al., 
2000;French et al., 2001;Jeffery & Utter, 2003;Stettler, 2002;Jequier, 2002;Poston & Foreyt, 
1999). A study based on the area of Washington showed that the main courses of children's 
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meals in US chain restaurants typically contain 700–900 calories, more than half the total 
recommended daily amount (Butler, 2004). The U.S. food supply provides 3800 kilocalories 
per person per day, nearly twice as much as required by many adults (Nestle, 2003). In 
addition, the physical activity decreased from year to year. The proportion of the U.S. 
population that reported no leisure-time physical activity was 31% in 1989, 29% in 1992, and 
25% in 2002 (U.S. Physical Activity Statistics, www.cdc.gov/). Another survey shows that 
more than 50% of American adults do not get enough physical activity to provide health 
benefits; 26% are not active at all in their leisure time (www.cdc.gov). 
 
2.3.2 Internal factors 
Environmental factors and lifestyle are important determinants influencing obesity, however, 
human obesity has also important genetic correlates that interact with relevant environmental 
factors (Comuzzie et al., 1994;Comuzzie et al., 1996;Comuzzie et al., 2001;Barsh et al., 
2000;Clement et al., 2002). Lifestyle factors, especially those related to physical activity levels, 
may interact with the genetic factors and may mask genotype influences (Bray, 2000;Martinez, 
2000). Twin studies, analyses of familial aggregation and adoption studies indicate that obesity 
is largely the result of genetic factors and that an individual's risk for obesity is increased when 
he or she has relatives who are obese (Stunkard et al., 1986a;Stunkard et al., 1986b;Stunkard et 
al., 1990;Sorensen et al., 1992;Vogler et al., 1995). Maes et al. concluded in their review article 
that genetic factors explain 50 to 90% of the variance in BMI from twin studies. Family studies 
generally report estimates of parent-offspring and sibling correlations in agreement with 
heritabilities of 20 to 80%. Data from adoption studies are consistent with genetic factors 
accounting for 20 to 60% (Maes et al., 1997). The importance of genes in the development of 
obesity can be estimated by calculating the family risk. Data obtained from NHANES III 
showed the prevalence of obesity is twice as high in families of obese individuals than in the 
normal population (Lee et al., 1997). Data from Canada Fitness Survey showed that the familial 
risk of obesity was five times higher for relatives in the upper 1% distribution of BMI than in 
the general Canadian population (Katzmarzyk et al., 1999).  
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The discovery of the ‘ob’ gene, which was mapped to human chromosome 7, has led to a 
renewed interest in understanding the patho-biological basis of genetic predisposition in 
obesity. The ‘ob’ gene encodes a hormone called leptin, a 167 amino acid protein that is 
produced in white and brown adipose tissue and placenta (Zhang et al., 1994). A case of human 
obesity caused by mutation of the leptin gene was first found in two severely obese cousin 
children in an inbred Pakistani kindred (Montague et al., 1997). Subsequently, the success in 
the treatment of congenital leptin deficiency with recombinant leptin was reported (Farooqi et 
al., 1999;Farooqi et al., 2002). Other single gene mutations causing human obesity were found 
in the leptin receptor (LEPR) (Clement et al., 1998), in the melanocortin precursor, pro-
opiomelanocortin (POMC) (Krude et al., 1998;Challis et al., 2002), and in the melanocortin-4 
receptor (MC4R) (Yeo et al., 1998;Hinney et al., 1999;Dubern et al., 2001;Farooqi et al., 
2003). Although obesity has a genetic component, normally, it is not a simple genetic disorder 
and cases of obesity caused by single gene mutation are extremely rare.  
 
2.4 Hypothalamus  
Leptin is secreted by adipocytes and its key role is that of communicating to the brain 
information on long term energy stores. The primary site for the leptin signal is in the 
hypothalamus (Figure 1.2), where it influences food intake/appetite and its absence triggers a 
series of neuroendocrine responses that conserve energy when food availability is limited.  
 
 
 
 
 
 
 
 
 
 
 Figure 1.2 Anatomy of human brain showing the hypothalamus and other components. 
hypothalamus thalamus 
corpus callosum 
cerebellum 
cerebrum 
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Energy balance is regulated by an interplay of hormonal and neural mechanisms in response to 
afferent information from peripheral adiposity signals such as leptin and insulin. It has long 
been recognized that the hypothalamus plays a key role in the mechanisms regulating food 
intake and fat accumulation (Anand & Brobeck, 1951a;Anand & Brobeck, 1951b;Kennedy, 
1950;Panksepp, 1974). The major hypothalamic regions implicated in adiposity signalling and 
regulation of food intake are shown in Figure 1.3. For instance, bilateral lesions of the 
ventromedial (VMH) or paraventricular nucleus (PVN) of the hypothalamus cause hyperphagia, 
decreased energy expenditure and pronounced weight gain (Leibowitz et al., 1981;Aravich & 
Sclafani, 1983). Conversely, lesions of the lateral hypothalamic area (LHA) induce hypophagia, 
increased energy expenditure and weight loss (Bernardis & Bellinger, 1993;Milam et al., 
1980;Milam et al., 1982). Electrical stimulation of this area causes hyperphagia and obesity 
(Bray et al., 1990;Hernandez & Hoebel, 1989;Shiraishi, 1991). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recent studies focused on the role of the hypothalamus reveal that several pathways in the 
central nervous system (CNS) forming a complex web of neuropeptide interactions are 
important for body weight regulation. The expression of orexigenic and anorexigenic genes 
shows contrary direction of regulation in response to fasting.  Starvation induces an increase in 
the gene expression of orexigenic neuropeptides such as neuropeptide Y (NPY) (Davies & 
Marks, 1994;Schwartz et al., 1992), agouti-related peptide (AgRP) (Hahn et al., 1998), 
Figure 1.3 Schematic representation of hypothalamic regions implicated in adiposity
signalling and regulation of food intake. Abbreviations of brain structures: AM, amygdala;
CC, corpus callosum; CCX, cerebral cortex; HI, hippocampus; ME, median eminence; OC, 
optic chiasm; SE, septum; TH, thalamus; 3V, third ventricle. 
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melanin-concentrating hormone (MCH) (Qu et al., 1996) and orexin (ORX) (Sakurai et al., 
1998). The gene expression of anorexigenic neuropeptides such as corticotropin-releasing 
hormone (CRH) (Brady et al., 1990;Fekete et al., 2000) and POMC (Bergendahl et al., 
1992;Brady et al., 1990) are depressed by starvation. These are also supported by other related 
studies (Adam et al., 2002;Bertile et al., 2003;Savontaus et al., 2002). Cocaine- and 
amphetamine-regulated transcript (CART) is normally categorized as an anorexigenic gene, 
which is downregulated by fasting (Robson et al., 2002). However, the effects of CART 
injection into different region of the hypothalamus are variable: intracerebroventricular (i.c.v.) 
injection reduced food intake (Asakawa et al., 2001;Volkoff & Peter, 2000) while injection into 
the area of arcuate nucleus neurons (ARC) increased food intake (Abbott et al., 2001;Kong et 
al., 2003). Furthermore, injections of NPY, AgRP, MCH, and ORX directly into the brain 
increased food intake (Qu et al., 1996;Sakurai et al., 1998;Morley et al., 1987;Rossi et al., 
1998), whereas CRH, and POMC derivatives such as α-MSH, have the opposite effect (Britton 
et al., 1982;Tsujii & Bray, 1989). Concerning the localization, NPY and AgRP are co-localized 
in ARC (Broberger et al., 1998;Hahn et al., 1998;Adam et al., 2002), POMC and CART are co-
localized in a distinct, but adjacent, subset of arcuate nucleus neurons (Elias et al., 1998;Adam 
et al., 2002). The arcuate nucleus transduces the information provided by the leptin signal into a 
neuronal response. This hypothesis is supported by the anorexic response to local 
microinjection of leptin into this area (Satoh et al., 1997), and the inability of i.c.v. leptin to 
reduce food intake after the arcuate nucleus has been destroyed (Tang-Christensen et al., 
1999;Dawson et al., 1997). A majority of both NPY/AgRP and POMC/CART neurons have 
been found to co-express leptin receptors (Baskin et al., 1999;Cheung et al., 1997) and both 
types of neurons are regulated by leptin, but in an opposing manner. Schwartz et al. also 
reported that leptin can suppress NPY and upregulate POMC (Schwartz et al., 1996;Schwartz et 
al., 1997). 
From ARC, the signals are mainly sent to the PVN (Gale et al., 2004) and other areas such as 
zona incerta, perifornical area (PF-A) and LHA, all of which are richly supplied by axons from 
arcuate nucleus NPY/AgRP and POMC/CART neurons (Elmquist et al., 1998;Elmquist et al., 
1999). In the PVN, several neuropeptides such as CRH (Bray et al., 1990;Fekete et al., 2000), 
thyrotropin-releasing hormone (TRH) (Kow & Pfaff, 1991), and oxytocin (McMahon & 
Wellman, 1997;Blevins et al., 2003) were found to reduce food intake. Whereas in the LHA 
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and adjacent areas such as PF-A, MCH (Qu et al., 1996;Saito et al., 1999) and orexins A and B 
were found as orexgenic peptides (Hagan et al., 1999;Sakurai et al., 1998). 
 
2.5 Animal model for research 
The first recorded use of mice as research animals occurred in 1664, when the English physicist 
Robert Hooke studied the reactions of mice in experiments on air. The remarkable genetic 
similarity of mice to humans, combined with great conveniences of small size and inexpensive 
maintenance, accounts for mice so often being the experimental model of choice in research. 
Over the past two decades, the mouse has emerged as the preeminent model organism because 
of many physiological, anatomical and metabolic parallels with humans (Bradley, 2002). The 
mouse and human genomes each contains about 30,000 protein-coding genes. The proportion 
of mouse genes with a single identifiable orthologue in the human genome seems to be 
approximately 80%, while less than 1% of mouse genes has not any homologue detectable in 
the human genome (and vice versa) (Mouse Genome Sequencing Consortium, 2002).  
Since the obese (ob) mouse and the diabetes (db) mouse were discovered at The Jackson 
Laboratory in 1950 and 1966 respectively (www.jax.org), obesity research has been developed 
accelerative. And then, the obesity research was forever changed when leptin was cloned and 
identified as the responsible mutation for the obese phenotype of the ob/ob mice in 1994 
(Zhang et al., 1994). Later on, after the leptin receptor was cloned (Tartaglia et al., 1995), 
Friedman's group found that the mutation in the leptin receptor gene was responsible for the 
obese phenotype of the db/db mice (Lee et al., 1996). Inbred strains have long been used for 
genetic studies because of the isogenicity within a strain and the genetic heterogeneity between 
inbred strains. Although the knock -out, -in and –down mice are applied to investigate the 
function of specific genes, the inbred strain mice are still mainly animal models for obesity 
research because obesity is a polygenic disease. The quantitative trait loci (QTL) studies have 
identified many loci (QTL) that control measurable polygenic traits related to obesity 
(www.obesitygene.pbrc.edu).  
In humans, not everyone becomes obese, even for the high fat consumers, not all of them tend 
to obesity (Macdiarmid et al., 1996). Bachmanov et al. investigated male mice from 28 inbred 
strains and found that the strain differences were significant for all of their analyses: body 
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weight, food and water intake, and spout preference (Bachmanov et al., 2002). In this atudy it 
was also shown that AKR/J mice were heavier and ate more (diet g/mouse) than SWR/J mice. 
However, if the food intake was adjusted by body weight, SWR/J mice ate more (diet g/body 
weight g) (Bachmanov et al., 2002). In other studies with respect to the preference of 
macronutrient diet selection, the lean strain of SWR/J consumed more calories from 
carbohydrate diet whereas AKR/J consumed more calories in form of fat (Smith et al., 
1997;Smith et al., 1999;Smith et al., 2000;Smith et al., 2001). The sensitivity of dietary obesity 
was reported by West et al., when exposed to high fat diet, AKR/J mice consumed more energy 
and had more fat content (West et al., 1992;West et al., 1995). For these two inbred mouse 
strains – AKR/J (diet-induce obesity model, DIO) and SWR/J (diet-resistant model, DR), 
although many dietary studies were reported, only Prpic et al. investigated strain specific 
differences in the gene expression of uncoupling protein (UCP) 1 and 2 in adipocytes during 
diet-induced obesity (Prpic et al., 2002). They reported that HF diet induced a modest increase 
in brown adipose tissue (BAT) UCP1 mRNA in SWR/J mice, whereas a large decrease in 
UCP1 expression in AKR/J mice, and that UCP2 was consistently higher in white adipose 
tissue (WAT) from AKR/J than in SWR/J mice and induced by the HF diet in AKR/J but not 
SWR/J mice (Prpic et al., 2002).  
 
2.6 Aim of this study  
As described above, many genes related to obesity are expressed predominantly in the 
hypothalamus. Even so, the genetic etiology of obesity is still unclear and the effective 
pharmaceutical treatment is still in the development stage. In order to investigate the 
differences of body weight, body fat content and food (energy) intake as a function of different 
diets and strains, AKR/J and SWR/J mice were to be fed either a high fat diet or a standard 
control diet. Furthermore, the influence of the different diets and strains on the hypothalamic 
gene expression was investigated using array technology – RZPD high density cDNA filter and 
Affymetrix GeneChip, to identify differentially expressed genes involved in the regulation of 
body weight and “energy turnover”. For the candidate genes selected from array data analysis, 
validation was to be carried out by northern blot analysis and in situ hybridization.
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3 Materials and Methods  
3.1 Diet experiment  
The two inbred mouse strains – AKR/J and SWR/J were purchased from The Jackson 
Laboratory (Bar Harbor, ME, USA) and bred in our animal house. The mice were maintained 
on a 12:12-h light-dark photoperiod with lights on at 6:00 a.m. CET at an ambient temperature 
of 25°C and fed control diet (Standard 1413, Altromin).  
Totally, 20 litters AKR/J mice yielding 104 individuals and 29 litters SWR/J mice yielding 207 
individuals were included in the experiment. Offspring were weaned at 21 days and separated 
into single cage and fed the control diet for 2 weeks. At the age of 35 days, they were assigned 
to two diet groups matched for body mass – one group of mice remained on control diet, while 
the other group was switched to a high fat diet (Sonder C1057, Altromin). The compositions of 
the two different diets used in the diet experiment are shown in Table 3.1. Body mass (± 0.1 g) 
and food intake (± 0.1 g) of each mouse was determined every 3 days from day 21 to day 35 
and then every 2 days until day 45.  
 
 
 
 Contents  Control diet High fat diet 
Fat (Energy %) 13.4 40.2 
Protein (Energy %) 28.9 23.9 
Carbohydrate (Energy %) 57.7 35.9 
Water content (weight %) 6.5 6.0 
Gross energy (KJ/g dry) 18.3 20.7 
Assimilated energy (KJ/g dry) 14.2 ± 0.2 18.2 ± 0.1 
Assimilation efficiency (%) 77.6 87.9 
 
On day 45 mice were killed in deep CO2 anesthesia for the dissection of hypothalamus or intact 
brain and several other selected organs (liver, kidney, inter scapular brown adipose tissue, 
inguinal and retroperitoneal white adipose tissue, and skeletal muscle). After weighing 
(± 0.001 g), all tissues were snap frozen and archived at -80°C. In a subset of individuals, only 
Table 3.1 Metabolic characteristics of control and high fat diet as determined by the 
supplier (Altromin). 
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the hypothalamus was removed and then body composition (fat + lean mass) was measured 
using Dual-Energy X-ray Absorptiometry (DEXA PIXImus, GE Medical Systems, Wisconsin, 
USA). In the group of mice used for in situ hybridization, the intact brain was removed from 
the skull, placed on aluminum foil on dry ice for at least 30 min to allow freezing through and 
subsequently stored at –80°C.   
 
3.2 RNA manipulations  
3.2.1 RNA isolation 
Hypothalamic RNA was isolated with TRIZOL® Reagent (Invitrogen), which is a mono-phasic 
solution of phenol and guanidine isothiocyanate, and an improvement to the single-step RNA 
isolation method developed by Chomczynski and Sacchi (Chomczynski & Sacchi, 1987).  
The hypothalami were transferred from the freezer (-80°C) to the lab bench in liquid nitrogen. 
Each sample was homogenized in a 4 ml tube containing 1 ml of TRIZOL, using a Ultra-turrax 
homogenizator (Janke und Kunkel GmbH) for 30 sec. Following a short centrifugation at 1000 
rmp for 1-2 min, the homogenized sample was transferred into a 1.5 ml tube and total RNA was 
isolated according to the manufacturer’s protocol. 
To purify the isolated RNA, the RNeasy Mini Kit (QIAGEN) was used according to the 
manufacturer’s protocol. 
 
3.2.2 RNA electrophoresis 
The hypothalamic RNA was denatured with formamide and separated in denaturing 
formaldehyde agarose gel. 100 ml of a 1% agarose gel was prepared by dissolving 1 g 
RNase-free agarose in 85 ml of ddH2O. 10 ml of 10 x MOPS and 5 ml of formaldehyde (3.5 %, 
Merck) were added after cooling the melted agarose below 60°C.  
Each RNA sample was pretreated by mixing 10 µl of denature buffer and 2 µl of ethidium 
bromide (0.5 mg/ml), followed by denaturation at 68°C for 15 min and quick cooling on ice for 
5 min. Then 6 x color buffer was added to the samples and they were loaded to the wells of the 
gel. Electrophoresis was conducted at 5-8V/cm in 1 x MOPS for 1-2 h. The ethidium 
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bromide-stained RNA in the gel was visualized by 302 nm UV light and pictures were taken 
with Gel Imager (Intas). 
 
Denature buffer (1.25 ml):  6 x color buffer (1ml):   
750 µl formamide   300 µl ddH2O  
150 µl 10x MOPS   500 µl glycerol (86%) 
250 µl formaldehyde   100 µl 2.5 % bromophenol blue 
100 µl ddH2O    100 µl 2.5 % xylene cyanol 
        2 µl EDTA (0.5 M; pH 8.0)  
10 x MOPS:                  
200 mM MOPS 
50   mM NaOAc 
10   mM EDTA-Na2        
 
3.2.3 RNA transfer 
The RNA in the electrophoresis gel was transferred to a neutral nylon membrane (Hybond N, 
Amersham) by Northern blotting (Sambrook & Russell, 2001). After 16-20 h of transfer, the 
membrane was placed on an UV transilluminator (UV-Stratalinker, Stratagene) and briefly 
irradiated at 254 nm to link the RNA to the membrane.    
 
3.2.4 Northern hybridization 
Northern hybridization (DNA-RNA hybridization) was accomplished as described by 
Sambrook and Russell (Sambrook & Russell, 2001). 
The probes were synthesized from cDNA fragments (see chapters 3.3.2 to 3.3.5) digested by 
restriction nucleases and labeled with α-32P-dCTP (ICN or Amersham) using the Rediprime II 
Randome Prime Labelling System (Amersham). Subsequently, probes were purified with the 
beta-Shield Device System (Stratagene). After overnight hybridization at 64°C and stringent 
wash, membranes were exposed to Kodak X-QMAT film (Scientific Image Film, Kodak) or 
Phosphor Imager screen (Molecular Dynamics). The screen was scanned with PhosphoImaging 
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(Storm, Molecular Dynamics) and the signal intensities were densitometrically quantified using 
the software package ArrayVision (Imaging Research Inc.). 
 
3.3 DNA manipulations  
3.3.1 Genomic DNA isolation  
Mouse genomic DNA was isolated from tail biopsy. About 0.5 cm of the tail tip was clipped, 
put into a polypropylene microfuge tube, and then digested overnight in 0.5 ml DNA digestion 
buffer at 50-55 °C. 
 
DNA digestion buffer:        
50 mM Tris-HCl pH 8.0 
100 mM EDTA pH 8.0 
100 mM NaCl 
1% SDS 
            0.5 mg/ml proteinase K (fresh)           
 
Neutralization was carried out in 0.7 ml of phenol/chloroform/isoamyl alcohol (25:24:1) at RT 
for 30 min at gentle agitation. Samples were then centrifuged at 15000 rpm for 10 min at RT 
and the upper phase (0.5 ml) was transferred to a new microfuge tube. DNA was precipitated in 
1 ml of 100% ethanol and centrifuged at 15000 rpm for 10 min at 4°C. After brief washing in 
1 ml of cold 70% ethanol, DNA was pelleted at 15000 rpm for 5 min at 4°C. The supernatant 
was discarded and the DNA pellet was air-dried. The DNA was redissolved in 50 µl of TE 
buffer at 60°C for 15 min and then stored at -20°C.   
 
3.3.2 Plasmid DNA preparation from E. coli cells 
The cDNA clones in E. coli cells were purchased from RZPD German Resource Center for 
Genome Research, Berlin, Germany. On arriving, the E. coli cells were transferred to 
LB/ampicillin plates and cultured overnight at 37°C followed by overnight culture in LB 
medium containing ampicillin (50 µg/ml).  
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LB-medium (1 l):    LB/ampicillin plate (1 l):      
10g tryptone     15 g agar in 1 l of LB-medium 
  5g yeast extract    100 µg/ml Ampicillin    
  5g NaCl       
pH was adjusted to 7.0 with NaOH  
 
Plasmid DNA was isolated with QIAprep Spin Miniprep Kit (Qiagen) from the overnight liquid 
culture according to the manufacturer’s protocol.  
  
3.3.3 Precipitation of plasmid DNA 
Contamination by small nucleic acid fragments, protein and salt can be reduced to acceptable 
levels by precipitating the DNA in 2.5 volumes of ethanol and 1/10 volume of 3.0 M NaAc (pH 
5.2). The sample was mixed, kept at -20ºC for more than 30 min and centrifuged at 14000 rpm 
for 10 min at 4ºC. The supernatant was discarded and the pellet was washed in cold 70% 
ethanol with subsequent centrifugation at 12000 rpm for 10 min. The purified DNA pellet was 
completely air-dried and then dissolved in TE buffer. 
 
3.3.4 DNA electrophoresis  
Agarose gel DNA electrophoresis is a standard method to separate and purify DNA fragments. 
An agarose gel of 0.8-2.0% (w/v) was prepared by boiling agarose in 1 x TAE buffer and 
pouring it into a gel casting tray. DNA samples were mixed with 1/6 volume of 6 x DNA 
loading buffer. The samples and an appropriate DNA marker (NEB) were separated at 10 V/cm 
for 0.5 - 2 h in 1 x TAE buffer containing ethidium bromide (0.2 µg/l). The ethidium bromide-
stained DNA in the gel was visualized by 302 nm UV light and pictures were taken with Gel 
Imager (Intas). 
 
 
 
 
  Materials and Methods 
 
 19
1 x TAE buffer:   6 x loading buffer (1ml):   
40 mM Tris-HCl   300 µl ddH2O 
0.35% glacial acetic acid  500 µl glycerol (86%) 
1 mM EDTA (pH 8.0)  100 µl 2.5 % bromophenol blue 
(0.2 µg/l ethidium bromide)  100 µl 2.5 % xylene cyanol 
     2 µl EDTA (0.5 M; pH 8.0)  
 
3.3.5 Digestion of DNA by restriction endonucleases  
Plasmid DNA (200 ng – 5 µg) was digested by restriction endonuclease(s), using the 
appropriate reaction buffers. The amount of enzyme, DNA, buffer composition and the duration 
of the reaction varied depending on the specific requirements of the emzyme (in general: 37°C 
for 1 h to overnight). In case where it was necessary to treat the same DNA sample with 
different enzymes, the digestion was either carried out in a buffer compatible to different 
enzymes, or first in the enzyme buffer of lowest salt concentration, and then the salt 
concentration was increased to proceed with another enzyme. 
 
3.3.6 DNA isolation from agarose gel 
The resulting restriction fragments were separated in agarose as described in chapter 3.3.4. 
Under UV light, the appropriate DNA band was cut out and DNA purification was carried out 
with QIAquick Gel Extraction Kit (Qiagen) according to the manufacturer’s protocol.  
 
3.3.7 PCR 
The Polymerase Chain Reaction (PCR) is an in vitro technique used to amplify a specific region 
of DNA, which lies between two oligonucleotide sequences (primers). PCRs were 
accomplished with Taq polymerase (Invitrogen) according to the modified manufacturer’s 
protocol. All primers used in this study (Table 3.2) were synthesized by MWG Biotech. The 
PCR reactions took place in a Personal Cycler (Biometra). RT-PCR was carried out using 
SUPERSCRIPTTM II RNase H – Reverse Transcriptase (Invitrogen) according to the 
manufacturer’s protocol.  
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PCR protocol: 
Component   Volume  Final concentration       
10x PCR buffer    5    µl   20 mM Tris-HCl (pH8.4) 
       50 mM KCl 
MgCl2 (50 mM)    1.5 µl   1.5 mM 
dNTP mixture (2.5 mM)   4    µl   0.2 mM 
0.1 % gelatine     0.6 µl   1.2‰ 
100 % DMSO     2.6 µl   5.2 % 
ddH2O    32.3 µl 
Forward primer (10 pmol/µl)   1    µl   0.2 pmol/µl 
Reverse primer (10 pmol/µl)   1    µl   0.2 pmol/µl 
cDNA      1    µl 
Taq Polymerase (1U/µl)   1    µl   20 U/ml    
Final volume   50    µl 
 
A typical PCR program consisted as follows: 
Step    Temperature   Duration  
(1) Initial denaturation:  94°C   2 min 
(2) 25-30 cycles: 
Denaturation:   94°C   1 min 
Annealing:   50-60°C  1 min 
Extension:   72°C   2 min 
(3)  Final extension:   72°C            10 min   
 
 
         
Name Sequence 
Glo1 primer forward ACCCCAGCACCAAGGATTTTCTAC 
Glo1 primer reverse ATTTTCCCGTCATCAGGCTTCTTC 
J0157-Lisch primer forward CCTCGGGCCCGCTCTGTGGAT 
J0157-Lisch primer reverse AAGGCGGAGGTGCTGGGGGATAGT 
L2249-Ppp3 primer forward TTGGTAAAAGAAGGGCGGGTGGAT 
Table 3.2 Primer sequences for the amplification of candidate genes identified from data 
analysis II (chapter 4.4.2.1) 
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L2249-Ppp3 primer reverse GCAAGGGGCAAGCTGTCAAAAG 
2-A2416-primer forward ATTCCGCCAAGCCCGTTCC 
2-A2416-primer reverse GCGCCTAGCAGCCGACTTA 
J2454-atp1a1 primer forward GCCCAGAAACCCCAAAACGGACAA 
J2454-atp1a1 primer reverse TAGGGGAAGGCACAGAACCACCAT 
B0812-(rik) primer forward GTATGCGCCACCGGAAAGGAC 
B0812-(rik) primer reverse AGCGGCCGCCATGAACTGTAA 
L2441-T7-Skp1a primer forward AAGATGACCCTCCTCCTCCTG 
L2441-T7-Skp1a primer reverse GTACCTGGGCCTCTTCCTCTT 
O0316-T7-Ubqln2 primer forward CCGGCGGCGACGACATCAT 
O0316-T7-Ubqln2 primer reverse GCGGCATTCAGCATAGGTTCTTG 
 
3.3.8 PCR purification 
The QIAquick PCR purification kit (Qiagen) was used to purify PCR products from the 
reaction mixture, which contained primers, nucleotides, polymerase and salts. PCR product 
purification was performed according to the manufacturer’s protocol. 
 
3.3.9 DNA ligation 
DNA ligation was carried out using the pGEM-T Easy Vector System (Promega) according to 
the manufacturer’s protocol. The A-tailing procedure of each purified PCR fragment was done 
according to the “Standard Tailing Procedure” in the manufacturer’s protocol. 
 
3.3.10 Transformation of E. coli 
2 µl of ligation reaction and 50 µl of Chemically Competent E. coli (Subcloning Efficiency 
DH5α, Invitrogen) were mixed and incubated on ice for 30 min. Uptake of DNA was induced 
by heat shock (45 s at 42°C), then the cells were diluted in 950 µl of SOC medium and 
incubated for 1 h at 37°C by rotating at 250 rpm. 100 µl of the cell suspension were plated on 
LB plates containing ampicillin and IPTG/X-Gal (MBI Fermentas), and cultured overnight at 
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37°C. On the following day, the white colonies were selected for LB medium overnight culture 
and further experimental processing. 
 
SOC medium (100 ml):  
2 g tryptone 
0.5 g yeast extract 
0.5 g NaCl 
0.25 ml 1M KCl   
1 ml 2 M Mg2+ 
1 ml 2 M glucose      
 
3.3.11 DNA sequencing 
DNA sequencing was done by commercial sequencing (MWG Biotech). 
 
3.4 RZPD filter hybridization 
The high density cDNA Filters (Mouse Unigene Set - RZPD 1, RZPD German Resource Center 
for Genome Research, Berlin, Germany) were applied to investigate gene expression. A filter is 
a nylon membrane of 22 cm x 22 cm size with 24,532 individual clones printed on in duplicate 
(49,064 clone spots). There are 48 * 48 blocks per filter and 5 * 5 dots per block. In each block, 
one Kanamycin guide dot spotted in the center, one pair of Arabidopsis control gene clones 
spotted in fixed positions and 11 different duplicate clones spotted in the other 22 positions 
comprise a special pattern which ensures that the duplicate genes do not have the same 
neighbors.  
3.4.1 Quality control of filter 
The vectors into which the inserts were cloned contain the sequence of M13 primer. To check 
the quality of the filters, a quality control hybridization was done with radiolabeled 33P-M13. 
This ensures that the clones are spotted appropriately. First, the filter was stripped in the 
stripping solution (5 mM sodium phosphate buffer pH 7.2. 0.1% SDS) at 100°C: it was soaked 
from one edge and shaken gently till it had re-cooled to room temperature (approx. 30-45 min). 
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Then the filter was rinsed with TE (100 mM Tris-Cl. 10 mM EDTA. pH 8.0) and left in TE 
until the M13 hybridization was performed.  
The M13 oligonucleotide (MWG Biotech) was labelled with γ-33P ATP (ICN) using T4 
polynucleotide kinase (Roche). 
M13 labelling:         
M13 vector oligonucleotides (100 ng/µl)            100 ng  
10x T4 polynucleotide kinase buffer      2 µl 
T4 polynucleotide kinase (10.000 U/ml)      1 µl 
γ-33P ATP          3 µl 
ddH2O        13 µl             
Final volume       20 µl                  
The 20 µl of mixture was incubated for 30 min at 37°C. 
 
M13 hybridization:  
The labeled M13 sequence was hybridized in 25 ml of Amasino per filter over night at 25°C. 
Amasino:             
20% SDS       350 ml 
1M sodium phosphate buffer pH 7.2    130 ml 
5 M NaCl         50 ml  
ddH2O       470 ml             
Final volume               1000 ml                  
 
On the next day, the filter was washed with wash buffer (1% SDS. 40mM sodium-phosphate) 
2 x 30 min at 25°C and wrapped in Saran film. The filter was then exposed to a Phosphor 
Imager screen for 18 to 24 h. After scanning by PhosphoImaging (Storm, Molecular 
Dynamics), the filter was stripped twice and then wrapped in Saran film and kept at –20°C for 
4-6 weeks to let the radioactivity fully decay.  
 
3.4.2 Complex hybridization 
Prior to the complex hybridization, the filters tested (in section 3.4.1) were exposed to Phosphor 
Imager screen and checked again to assure that no radioactivity was left.  
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Four RNA pools were gathered from total RNA isolated from the hypothalami of male mice of 
the AKR/J Control, AKR/J HF, SWR/J Control and SWR/J HF group.  From the 4 different 
RNA pools radiolabeled 33P-cDNA was synthesized and hybridized with the high density 
cDNA Filters.  
 
3.4.2.1 Preparation of complex cDNA samples 
The complex cDNA samples – 1st strand cDNA were synthesized from total RNA using 
Superscript II RT (Superscript II Reverse Transcriptase Kit, Life Technologies).  
First, 10 µg of total RNA in ddH2O (for two filters) and 1 µg of dTV primer (anchored dT18; 
2 µl of 500 ng/µl) were mixed at RT and the final volume was adjusted to 10.5 µl with ddH2O. 
The mixture was heated for 10 min at 70°C and then immediately cooled on ice. Then the 
following reagents were added on ice in the order indicated:  
cDNA  labeling:           
 RNasin      0.5 µl 
5x first strand buffer     5.0 µl  
0.1 M DTT      2.5 µl  
20 mM dGTP, dATP, dTTP    0.5 µl  
[alpha-33P] dCTP (10 µCi/ul)     5.0 µl  
  
The reaction was prewarmed for 1 min at 37°C followed by the addition of 1 µl Superscript II 
RT (final reaction volume was 25 µl), and vortexed. The reaction was then incubated at 37°C 
for 1 to 2 h.   
The hydrolysis of RNA to generate single strand samples was carried out by adding 1 µl of 
0.5 M EDTA pH 8.0, 1 µl of 10% SDS and 3 µl of 3 N NaOH at RT and mixing after addition 
of each reagent. After incubation for 30 min at 68°C the mix was cooled to RT and then 1 µl of 
1 M Tris-HCl pH 8.0 and 3 µl of 2 N HCl were added. The final volume was 50 µl after 16 µl 
of ddH2O was added. 1 µl of the sample was transferred to 2 ml scintillation fluid and total 
activity was measured by a β-counter (Beckmann LS 3801, Beckman Instruments, Inc).  
In the last step the labeled cDNA was purified using an S-300 column (Mo Bi Tec). The resin 
in the S-300 column was resuspended and then the column was pre-spun for 1 min at 2500 rpm. 
After the cDNA was loaded onto the column it was centrifuged again at 2500 rpm for 2 min. 
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The volume of flow through and the activity of 1 µl in 2 ml scintillation fluid were measured. 
The percentage of labeled dCTP incorporation was calculated from these two activity 
measurements.  
Finally, the denatured sample was heated for 5 min at 100°C and immediately placed on ice. 
 
3.4.2.2 Pre-hybridization 
Each filter was wetted in 7.5 ml of ddH2O and then placed into roller bottle, avoiding formation 
of air bubbles between filter and glass. Salmon sperm DNA (10 mg/ml) was denatured for 
5 min at 100°C immediately placed on ice. For two filters, 30 µl of denatured DNA was added 
into the pre-warmed (65°C) 15 ml of 2x Denhardt's hybridization mix. Finally, 7.5 ml of 
2x Denhardt's hybridization mix was added. Because the roller bottle already contained 7.5 ml 
ddH2O the final concentration of Denhardt's hybridization mix was 1 x.  
Filters were pre-hybridized at least 2 hours at 65°C. 
 
2x Denhardt’s hybridization mix:     
20% SDS        2.5 ml 
20 x SSC      60   ml 
50 x Denhardt's buffer      20   ml  
ddH2O       17.5ml            
Final volume                 100 ml                  
 
50x Denhardt's buffer:      
Ficoll (Type 400)     5 g 
Polyvinylpyrrolidone     5 g 
BSA (Fraction V)     5 g          
 
The reagents for 50x Denhardt's buffer were dissolved in 400 ml ddH2O, stirred for a few hours 
and then adjusted to 500 ml with ddH2O. After filtered through a 0.45 µm filter, aliquots of 10 
and 50 ml were frozen at –20°C. 
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3.4.2.3 Complex hybridization 
The labeled cDNA samples prepared from each pool of total RNA (section 3.4.2.1) were added 
into the roller bottle and hybridized with the filters for 20 to 24 hours at 65°C. Each time, in 
complex hybridization, one pair of labeled cDNA samples was used, for instance, AKR/J 
control and HF or SWR/J control and HF.  
 
3.4.2.4 Post-hybridization 
The first 2 wash steps were done in the hybridization roller bottle (50 ml/bottle) at 65°C: 20 
minutes in wash buffer 1 (1x SSC, 0.1% SDS) followed by 10 minutes in wash buffer 2 
(0.3 x SSC, 0.1% SDS).  
Then the filters were transferred into a large plastic box and washed for 10 minutes in 500 ml 
wash buffer 2 at 65°C in a water bath. A maximum of 8 filters (added one by one) can be 
washed in one box. The shaking frequency of the water bath was not over 20 movements per 
minute to prevent the filters moving up the box walls and drying out.  
The last wash step was to rinse the filters 10 minutes in 500 ml wash buffer 3 (0.1x SSC, 0.1% 
SDS) at 65°C.  
Finally, the filters were taken out of the wash buffer, and remaining buffer was briefly allowed 
to drop off. Each filter was then wrapped in the Saran foil, avoiding air bubbles, crinkles and 
visible liquid drops.  
The wrapped filters were then exposed to a Phosphor Imager screen for 18 to 24 h followed by 
scanning with phosphoimaging (Storm, Molecular Dynamics) and image analysis using the 
software package ArrayVision (Imaging Research Inc.).  
Filters were stripped as described in section 3.4.1 and kept at –20 °C. After scanning, a filter 
can be re-used for 5 times. 
 
3.5 Affymetrix GeneChip hybridization  
The GeneChip® expression arrays (Murine Genome U74Av2) were purchased from Affymetrix. 
The Murine Genome U74v2 set, consisting of three GeneChip® probe arrays (A, B and C 
Chip), contains probe sets interrogating approximately 36,000 full-length mouse genes and EST 
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clusters from the UniGene database (Build 74). In this experiment only the A Chip was applied, 
which contains 12,488 genes.  
3.5.1 RNA isolation  
See section 3.2.1. 
 
3.5.2 cDNA synthesis  
3.5.2.1 First-strand cDNA synthesis 
The first-strand cDNA synthesis was carried out with Superscript II Reverse Transcriptase Kit 
(Life Technologies) with modification. The primer hybridization reaction, containing 5-20 µg 
RNA, T7-oligo (dT) primer 2 µl (50 µM) and DEPC-H2O to 11 µl, was incubated at 70°C for 
10 min and immediately placed on ice. Then 4 µl of 5 x first-strand cDNA buffer, 2 µl of 0.1 M 
DTT and 1 µl of 10 mM dNTP mix were added and incubated at 42°C for 2 min. Finally, 2 µl 
of Superscript II RT were added and the reaction was incubation at 42°C for 1 h.  
 
3.5.2.2 Second-strand cDNA synthesis 
The following reagents were added into the first-strand synthesis tube (20µl): 
 
Second-strand reaction composition:    
DEPC-H2O               91 µl 
5 x second-strand reaction buffer 30 µl 
10 mM dNTP mix     3 µl 
10 U/µl E. coli DNA Ligase    1 µl 
10 U/µl E. coli DNA polymerase I   4 µl 
2 U/µl E. coli RNase H    1 µl  
 Final volume             150 µl 
After brief centrifugation the mix was incubated at 16°C for 2 h, then 2 µl of T4 DNA 
polymerase were added and incubation was continued for another 5 min at 16°C. DNA was 
purified by adding 10 µl of 0.5 M EDTA. 
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3.5.2.3 Cleanup of double-strand cDNA 
Cleanup of the double-strand cDNA was carried out with the GeneChip Sample Cleanup 
Module (Affymetrix). After 600 µl of cDNA binding buffer were added to the 162 µl of final 
double-stranded cDNA, the sample was applied to the cDNA Cleanup Spin Column to 
centrifuge for 1 min at ≥ 8000 g (≥ 10000rpm). The spin column was washed with 750 µl of 
cDNA wash buffer by centrifugation for 1 min at the same speed, followed by additional 
centrifugation for 5 min at maximum speed (≤ 25000 g). The cDNA was eluted from the 
column by loading 14 µl of elution buffer onto the column, 1 min incubation at RT and 1 min 
centrifugation at maximum speed.  
  
3.5.3 cRNA synthesis 
The Enzo®BioArrayTMHigh YieldTM RNA Transcript Labeling Kit (Affymetrix) was used for 
generating labeled cRNA target.  
 
IVT cRNA labeling:     
Template cDNA    10 µl 
ddH2O     12 µl 
10 x HY reaction buffer    4 µl 
10 x biotin-labeled ribonucleotides   4 µl 
10 x DTT      4 µl 
10 x RNase inhibitor mix    4 µl 
20 x T7 RNA polymerase     2 µl  
 Total volume    40 µl 
After brief centrifugation the reaction was incubated at 37°C for 4-5 h. 
 
3.5.4 Cleanup and quantification of biotin-labeled cRNA 
The cRNA sample mixed with 60 µl of ddH2O, 350 µl of IVT cRNA binding buffer and 250 µl 
of ethanol (100%) was loaded to an IVT cRNA cleanup spin column (Affymetrix) and 
centrifuged for 15 sec at ≥ 800 g (10000 rpm). Then the column was washed with 500 µl of 
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IVT cRNA wash buffer and 500 µl of 80% ethanol by centrifugation twice for 15 sec at ≥ 800 g 
(10000 rpm). After an additional centrifugation for 5 min at maximum speed (≤ 25000 g), the 
cRNA was eluted twice with RNase-free water – first with 11 µl, then with 10 µl, by 
centrifugation twice for 1 min at maximum speed (≤ 25000 g). 
The purified cRNA was quantified with Ultrospec 2100 pro spectrophotometer (Amersham 
Pharmacia Biotech). The cRNA must be at a minimum concentration of 0.6 µg/µl. 
 
3.5.5 Fragmenting the cRNA for target preparation 
Fragmentation of cRNA target before hybridization onto GeneChip arrays has been shown to be 
critical in obtaining optimal assay sensitivity. 2 µl of 5 x fragmentation buffer was added for 
8 µl of cRNA, then the mix was incubated at 95°C for 35 min and immediately placed on ice. 
The fragmented cRNA was checked on RNA 6000 Nano Labchips (Agilent Technologies). 
 
3.5.6 GeneChip hybridization 
The hybridization cocktail was prepared as follows and then incubated at 99°C for 5 min 
followed by incubation at 45°C for 5 min. Finally, it was centrifuged at maximum speed for 
5 min.  
Hybridization cocktail :     
Fragmented cRNA     15 µg 
Control oligonucleotide B2 (3 nM)      5 µl 
20 x eukaryotic hybridization controls   15 µl 
Herring sperm DNA (10 mg/ml)      3 µl 
Acetylated BSA (50 mg/ml)       3 µl 
2 x hybridization buffer   150 µl 
H2O      124 µl  
Total volume     300 µl 
 
The GeneChip was equilibrated to RT and filled through one of the septa with 1 x hybridization 
buffer, followed by incubation at 45°C for 10 min with rotation. After removal of hybridization 
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buffer and refilling with hybridization cocktail, the chip was put into the hybridization oven for 
16 h at 45°C. 
 
12 x MES stock (1 l):     2 x hybridization buffer (50 ml):  
MES-free acid monohydrate  70.4 g    12 x MES          8.3 ml 
MES sodium salt   193.3 g   5 M NaCl       17.7 ml 
Molecular Biology Grade water 800 ml    0.5 M EDTA         4.0 ml 
After mix the final volume was adjusted to 1 l    10% Tween 20        0.1 ml  
and then filtered through a 0.2 µm filter.    ddH2O       19.9 ml  
 
3.5.7 Post-hybridization 
After 16 h of hybridization, the hybridization cocktail was removed and wash buffer (wash A) 
was filled into the GeneChip. The wash and stain steps (Table 3.3) were carried out in the 
fluidics station with the program edited in the connected computer.  
Table 3.3 Post-hybridization: procedure and buffer 
Post Hyb Wash 1 10 cycles of 2 mixes with wash A at 25°C Wash A: 6 x SSPE, 0.01% Tween 20
Post Hyb Wash 2 4 cycles of 15 mixes with wash B at 50°C Wash B: 100 mM MES, 0.1 M 
NaCl, 0.01% Tween 20 
Stain 10 min in SAPE solution at 25°C SAPE: 1 X MES, 2 mg/ml 
acetylated BSA, 10 µg/ml SAPE 
Post stain wash 10 cycles of 4 mixes with wash A at 25°C   
2nd stain 10 min in antibody solution at 25°C 
Antibody solution: 1 x MES, 2 
mg/ml acetylated BSA, 0.1 mg/ml 
normal goat IgG, 3 µg/ml 
biotinylated antibody 
3rd stain 10 min in SAPE solution at 25°C   
Final wash 15 cycles of 4 mixes with wash A at 30°C 
The holding temperature is at 25°C.   
After complete wash and staining the GeneChip was scanned with the GeneChip scanner 2500 
(Affymetrix) and the image was analyzed using the R software package (Bioconductor). 
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3.6 In Situ hybridization  
The principle behind in situ hybridization (ISH) is the specific annealing of a labelled nucleic 
acid probe to complementary sequences in fixed tissue, followed by visualization of the 
location of the probe. This technique was used here to locate and confirm the differentially 
expressed genes identified by the complex hybridization.   
3.6.1 Brain sectioning 
Coronal brain sections (16 µm) spanning the hypothalamic area were prepared from the intact 
brains with a cryosectioning system (Leica CM 3050). The object temperature was adjusted at –
13°C to –14°C after the brain was fixed on it at –50°C. The chamber temperature was 1-2°C 
lower than object temperature to avoid that the sections melted on the cryostat knife. The first 6 
sections were mounted on 6 slides (A1 to F1 in order), and then the second 6 sections were 
added in the same order, i.e., the distance between sections represented on one slide was 96 µm. 
When the first 6 slides were completed, another series of 6 slides (A2 to F2) was used for 
mounting new sections.   
 
3.6.2 Glass slide preparation – silanization 
For an initial wash, the glass slides (Menzel) were put into a box containing hot tap water and 
detergent for 1 h. They were rinsed 3 times in hot tap water for 15 min. Subsequently, they 
were washed once with deionized H2O and ddH2O for 15 min each. Finally, after being washed 
in 70% ethanol and shaken for 45 min they were dried overnight at 60°C. On the following day, 
they were washed once for 30 s with 2% TESAP in acetone and twice in 100% acetone. After a 
brief rinse with deionised H2O and ddH2O they were dried overnight at 42°C and stored at RT.  
 
3.6.3 Preparation of the probe 
3.6.3.1 Linearization of DNA template from section 3.3.3. 
The plasmid DNA was linearized by the digestion of the restriction enzyme close to the end of 
the insert to avoid transcription from the whole plasmid DNA by RNA polymerase. It is very 
important that there should be no more cutting between the restriction site (e.g., Spe I) and the 
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corresponding primer binding site (e.g., T7) (Figure 3.1). The plasmid DNA samples (5 µg – 
10 µg) were digested in two reaction tubes by one restriction endonuclease (either Spe I or 
Apa I) in each reaction using corresponding reaction buffer. The amount of enzyme, DNA, 
buffer composition and the duration of reaction varied depending on the specific requirements 
of the enzyme (in general: 37°C for 2 h to overnight). 
 
 
 
 
 
 
 
 
 
3.6.3.2 In Vitro transcription (IVT) 
From this step to hybridization, all solutions and devices used must be RNase free, i.e. DEPC 
treated solutions, and baked racks and stainless steel tanks, are necessary.  
For In Vitro transcription the following reagents were added in order indicated:  
                 10 - X µl DEPC H2O  
5  µl 5x transcription buffer 
X µl = approx. 1 µg DNA template  
1  µl 10 mM rCTP 
1  µl 10 mM rGTP 
1  µl 10 mM rATP  
1  µl 0.75 M DTT 
1  µl = 1 U RNase-Block I 
4  µl S35-UTP (50 µCi) 
                      1  µl T3 or T7 polymerase (all 20000 U/ml)                
The final volume was 25 µl. 
 
Insert T3 T7
Spe I Apa I
Figure 3.1 linearization of DNA template. The dark line shows part of the vector
sequence. The gray box in the middle shows the insert and the other two beside it
show the T3/T7 primer binding sites. At both ends of the insert there are restriction
sites by Spe I or Apa I. 
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This reaction was first incubated at 37°C for 1-1.5 h and then for 0.5-1 h after the addition of 
2 U DNase I. During this incubation a ChromaSpin 30 column (BD Biosciences) was prepared 
by resuspending the loading gel in the column and spinning at 1700 rpm for 5 min at 24°C. 
After incubation 25 µl DEPC H2O were added to the reaction and the final volume of 50 µl was 
pipetted onto the ChromaSpin column, and then centrifuged at 1700 rpm for 5 min. The probe 
can be stored at -20°C or -70°C for one week if required. 0.5 µl of the purified probe was taken 
out, diluted to 50 µl and then activity of 5 µl was measured by Beckmann LS 3801. 
 
3.6.4 Pre-hybridization 
The slides were brought to RT in a rack and fixed in 4% paraformaldehyde (PFA) in PBS for 
20 min on ice followed by 2 x 5 min washes in 0.1 M PBS (0.2 M diluted with DEPC H2O).  
Then the slides were immersed in 250 ml of 0.1 M TEA for 2 min; meanwhile, 625 µl of acetic 
anhydride (AA) (Sigma) was added to another dry tank. Subsequently, the 0.1 M TEA was 
poured from first tank into acetic anhydride tank, stirred quickly with a sterile tip or Pasteur and 
then the slides were immersed in this TEA/AA mix for 10 min. After two washes in 0.1 M PBS 
each lasting 2 min, the slides were dehydrated through gradient increasing concentration of 
alcohol – 50, 70, 95 and 100% ethanol/DEPC H2O for 3 min each step. Finally, they were air 
dried for 1-2 h.  
 
3.6.5 Hybridization 
The hybridization buffer and probe mixture were prepared by adding the following reagents and 
mixing well:  
Hybridization buffer (1.5 ml):  Probe mixture (400µl):  
300 µl 5 M NaCl       50 µl radioactive probe 
100 µl 50 x Denhardts   256 µl tRNA (3.9 mg/ml stock)  
  50 µl 1 M Tris (pH 8)    20 µl 1 M DTT 
  10 µl 0.5 M EDTA (pH 8)    74 µl DEPC H2O   
  40 µl DEPC H2O 
   1 ml 50% Dextran sulphate   
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50% dextran sulphate was prepared by dissolving 1 g of dextran sulphate in 1.5 ml DEPC H2O 
in a sterile 4 ml tube at 55-60°C for 2-3 h. After vortexing the solution can be immediately used 
or stored at 4°C. 
The final hybridization cocktail was prepared by mixing 400 µl of probe mixture and 1600 µl 
of hybridization buffer. The mixture can be stored at -20°C (for 1 week) if necessary. 
The radioactivity of the 2000 µl probe was determined. The optimal range of radioactivity is 
80000 – 150000 cpm in 10 µl. 
50-60 µl of the final hybridization cocktail was loaded to each slide. The slides were covered 
by cover slips and incubated for 16-22 h at 60°C in the hybridization oven.  
 
3.6.6 Post-hybridization 
The slides were taken out of the oven and cooled to RT. Subsequently, they were soaked in 4 x 
SSC for 30 min to loosen cover slips. The cover slides were removed by joggling and each slide 
was transferred to another rack in a tank containing 4 x SSC. When all slides were in the rack, 
they were washed four times in 4 x SSC, 5 min each. After incubation in RNase solution at 
37°C for 30 min, the slides were washed in a series of gradient decreasing concentration of SSC 
dilutions and dehydrated in a series of gradient increasing concentration of ethanol solutions.  
  
RNase solution:       Slide wash:        Slide dehydration: 
25 ml 5 M NaCl  
2.5 ml 1 M Tris (pH 8) 
0.5 ml 0.5 M EDTA 
0.5 ml RNase (10 mg/ml) 
222ml dd H2O   
 
3.6.7 Signal detection 
The well-dried slides were fixed in an X-ray cassette and exposed to BioMax MR Film (Kodak) 
for 3-7 days. 
 
4 x SSC RT 4 x 5 min 50% ethanol RT 1 x 3 min
2 x SSC RT 2 x 5 min 70% ethanol RT 1 x 3 min
1 x SSC RT 1 x 10 min 95% ethanol RT 1 x 3 min
0.5 x SSC RT 1 x 10 min 100% ethanol RT 1 x 1 min
0.1 x SSC 60°C 1 x 30 min    
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3.7 Quantitative real-time RT-PCR 
Quantitative real-time reverse transcription polymerase chain reaction (real-time RT-PCR) is 
based on the detection of fluorescence produced by a reporter molecule – e.g., SYBR® Green I, 
which binds to double-stranded DNA (dsDNA) but not to single-stranded DNA. In real-time 
RT-PCR, as PCR product – dsDNA accumulates, the fluorescent dye generates a signal that is 
proportional to DNA concentration and that can be measured using instruments.  
 
3.7.1 First-strand cDNA synthesis 
Hypothalamic RNA isolation is described in section 3.2.1. SuperScriptTM III Platinum® 
Two-Step qRT-PCR kit (Invitrogen) was used to generate first-strand cDNA for real-time 
RT-PCR. 1 µg RNA was added into a tube containing 10 µl of 2 x RT Reaction Mix and 2 µl of 
RT Enzyme Mix. DEPC-treated water was filled up to the final volume of 20 µl. After gentle 
mixing, the reaction was incubated at 25°C for 10 min and at 42°C for 50 min. Subsequently, 
the reaction was terminated at 85°C for 5 min and chilled on ice. Finally, 1 µl (2U) of E. coli 
RNase H was added followed by incubation at 37°C for 20 min. The first-strand cDNA was 
diluted with DEPC-treated water to 100 µl.  
 
3.7.2 Primer design 
Primers (Table 3.4) were designed at www.invitrogen.com using the primer design software – 
OligoPerfectTM Designer and synthesized by MWG Biotech. The amplicon length defined by 
the primer was approximately 80–250 bp to optimize the efficiency of real-time RT-PCR. 
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3.7.3 Real-time RT-PCR protocol and program 
Fluorescein (Bio-Rad) was added to the Platinum® SYBR® Green qPCR SuperMix UDG 
(Invitrogen) as internal reference to a final concentration of 20 nM. Each real-time qRT-PCR 
reaction contained 25 µl of Platinum® SYBR® Green qPCR SuperMix UDG with fluorescein, 
1 µl of forward and reverse primer (10 µM) respectively and 1 µl of first-strand cDNA (see 
3.7.1) and DEPC water to a final volume of 50 µl. Beta actin was used as standard gene for 
control because it is expressed identically in all cells.  
A typical real-time RT-PCR cycling program using the iCyclerTM (Bio-Rad) is shown below: 
Cycle  1: (  1X)  
 Step  1:   50.0ºC for 2 min 
 Step  2:   95.0ºC for 2 min  
Cycle  2: ( 45X)  
 Step  1:   95.0ºC for 15 sec 
 Step  2:   55.0ºC for 30 sec 
 Step  3:   72.0ºC for 30 sec 
 Data collection enabled. 
Cycle  3: (100X)  
 Step  1:   70.0ºC for 7 sec 
 Increase setpoint temperature after cycle 2 by 0.2ºC 
 Melt curve data collection and analysis enabled.  
Cycle  4: (  1X)  
 Step  1:    4.0ºC for 5 min 
Name Sequence 
Glo1 primer forward ATGCCTCATGGTACCTCCTG 
Glo1 primer reverse TCCCCTAGAGCAGCCTTGTA 
Hba-α1 primer forward GACGTTGGTTAGCCACCAC    
Hba-α1 primer reverse CTGCAGAAGGGAGCTTATCG 
Ppp3cb primer forward GAGGAGAGCAGTGAGCAAGG    
Ppp3cb primer reverse GGGGGAGTTCCACGTTATCT    
TNFAIP1 primer forward CCTGGGCTCAATCTCCAGTA    
TNFAIP1 primer reverse GGTCCTGGCACTCTGCTTAG    
Table 3.4 Primer sequences for real-time RT-PCR. 
  Materials and Methods 
 
 37
The fluorescence in each well of the 96-well plate was measured after each extension step 
(Cycle 2, Step 3) during the PCR reaction. As DNA is synthesized, more SYBR Green will 
bind and the fluorescence will increase.  
 
3.8 Data analysis  
Totally 3 sets of data analysis were done. The first set (Data analysis I) was from 8 filters 
hybridized with the probes synthesized from the first set of 4 RNA pools – 2 RNA samples for 
each group. The second set of RNA pools was gathered from the selected RNA after 
transthyretin screening in Northern blot – 11 from SWR/J control groups as well as HF, and 5 
from AKR/J control groups as well as HF. Data analysis II was done using the second set of 
data coming out of second 8 filter hybridizations and 8 GeneChip hybridizations with the same 
second set of RNA pools.  Data analysis III was focus on the data from second filter 
hybridization.  
 
3.8.1 Data analysis I 
The signal intensity of each spot on the filters was determined using ArrayVision procedure AR 
VOL that means artifact-removed density value multiplied by its area. To reduce biasdue to 
technical varision between filters quantile normalization was done for filters using AR VOL 
data corrected with local background. The local background was median intensity of one 
Kanamycin and one pair of Arabidopsis spots in each 5*5 block. For each spot, the intensity 
after background correction was transformed to log2. Next, for each filter the average intensity 
of the duplicate genes was calculated, and then the average intensity of this gene on two 
repeated filters was calculated. An MA plot was made for each comparison, where M means the 
difference of log2-intensity of one gene at two conditions and A means the mean of 
log2-intensity of one gene at two conditions, in other words, M shows log2-ratio (fold change = 
2M) and A shows mean intensity. The candidate genes were selected according to the MA plot 
using a threshold of > 2 fold change in the following 4 comparisons: AKR/J Control vs. AKR/J 
HF, SWR/J Control vs. SWR/J HF, AKR/J Control vs. SWR/J Control and AKR/J HF vs. 
  Materials and Methods 
 
 38
SWR/J HF. Low quality spots were detected and eliminated by checking the differences 
between the duplicates on filter in relation to the M values.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.8.2 Data analysis II 
The second set of data from 8 RZPD cDNA Filter hybridizations and 8 Affymetrix GeneChip 
hybridizations was analyzed with different strategy. 
 
  Table 3.5 Array hybridization with the same original RNA pools. 
RNA pools  RZPD cDNA Filter Affymetrix GeneChip 
AKR/J Control 2 x 2 x 
AKR/J HF 2 x 2 x 
SWR/J Control 2 x 2 x 
SWR/J HF 2 x 2 x 
 
The data (AR VOL) from filter hybridization were first corrected with the local background – 
medium intensity of one Kanamycin and two Arabidopsis spots within each 5 x 5 block. And 
then, all filters were complemented in a quantile normalization, followed by the 4 different 
M 
A
Figure 3.2 MA blot of AKR/J control vs. AKR/J HF. M shows difference
of log2-intensity of one gene at two conditions while A is the mean of
log2-intensity of one gene at two conditions. The selected candidate genes 
were marked as “▲”. 
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comparisons: AKR/J Control vs. AKR/J HF, SWR/J Control vs. SWR/J HF, AKR/J Control vs. 
SWR/J Control and AKR/J HF vs. SWR/J HF. MA plot and M – z-scores plot were made for 
each comparison, where z-scores tells how many standard deviations away from the mean of M 
value at this intensity a score resides. The list of candidates was sorted out through several 
criteria: intensity (A), z-scores, fold-change (M), and differences of one gene between two 
replicate filters and between the duplicates within one filter. The threshold of >2 fold change 
was defined for filter data analysis while >1.7 fold change for chip. 
The data from GeneChip hybridizations were treated with the similar analysis method as 
described above.  
In filter data, the genes were listed with RZPD clone ID (e.g., IMAGp952F2058) and GenBank 
accession number (e.g., ai226516, ai266816). However, in chip data the genes were list with 
Affy ID (e.g., 103361_at). By Internet database searching (DAVID Annotation Tool, 
http://apps1.niaid.nih.gov/david/), the list of Affy ID was converted to UniGene cluster. The 
GenBank accession number was converted to UniGene cluster as well. And then the selected 
candidate lists from filter and chip analyses were compared and the overlapped genes in each of 
the 4 comparisons were listed out as the analysis result.  
The candidates were rechecked and the low quality candidates were eliminated through another 
approach – direct going over in the original image of filter.  
 
3.8.3 Data analysis III 
Only the filter data from the second complex hybridization were used in analysis III. The data 
were dealt with as described in 3.8.2 followed by only two comparisons – AKR/J Control vs. 
AKR/J HF and SWR/J Control vs. SWR/J HF.  
 
3.9 Post analysis  
After each analysis, the clones of some candidates were obtained from RZPD, followed by over 
night culture, sequencing, cloning, probe labeling and then Northern blot analysis, In Situ 
hybridization and real-time RT-PCR. 
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3.10 Single nucleotide polymorphism (SNP) analysis 
Single nucleotide polymorphism (SNP) analysis of mouse gene Glo1 was carried out by 
Kathrin Reichwald in the Department of Genome Analysis, Institute of Molecular 
Biotechnology (IMB), Jena, Germany.  
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4 Results 
4.1 Diet induced obesity in mice 
4.1.1 Body mass 
In weanlings of either strain, body mass increased rapidly from day 24 to 35 by about 8-14 g, 
corresponding to the maximal growth spurt in mice. After 2 days on the high fat diet, the body 
mass in the AKR/J high fat diet groups was already 1.5 to 2.0 g higher than in the controls 
(Table 4.1 and Figure 4.1). After 10 days on the diet experiment, both female and male AKR/J 
mice fed the high fat diet were significantly heavier than mice in the control groups. In contrast, 
body mass of both male and female SWR/J mice showed no difference between the high fat 
diet and control groups. In corresponding feeding groups, AKR/J mice were heavier than 
SWR/J mice.  
 
Table 4.1 Effect of different diets on body mass. 
a C: control diet; HF: high fat diet. 
 
 
 
 
 
Body mass (mean ± SD) (g) 
Strain 
Diet groupa and 
number of mice Day 21 Day 35 Day 45 
Female C: n = 10 
Female HF: n = 8 
8.95 ± 2.39 
8.85 ± 2.14 
19.88 ± 2.16 
19.70 ± 1.88 
21.51 ± 1.98 
23.61 ± 2.76 
AKR/J 
(37 mice in 
8 litters) 
Male C: n = 10 
Male HF: n = 9 
10.27 ± 2.31 
10.52 ± 2.22 
23.69 ± 2.65 
23.77 ± 2.57 
26.07 ± 2.51 
29.01 ± 3.30 
Female C: n = 30 
Female HF: n = 25 
8.17 ± 0.71 
8.35 ± 0.67 
16.28 ± 0.99 
16.24 ± 0.85 
17.08 ± 0.96 
17.56 ± 0.93 
SWR/J  
(104 mice in 
14 litters) 
Male C: n = 27 
Male HF: n = 22 
8.65 ± 1.29 
8.54 ± 0.97 
20.96 ± 1.79 
20.76 ± 1.19 
21.77 ± 1.48 
21.84 ± 1.18 
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Figure 4.1 Effect of diet on body mass in two inbred mouse strains fed either control (C –●–) or 
high fat (HF –■–) diet. n = 8-30 individuals per group (Table 4.1). Data indicate means ± SD. 
The dotted lines match the day of diet change for the HF groups.   
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4.1.2 Energy intake  
After weaning, during the first two weeks at the control diet, all mice consumed comparable 
amounts of energy per day, regardless of strain. Energy intake (food intake (g) * energy content 
of diet (KJ/g)) was slightly higher in males than in females, corresponding to sexual 
dimorphism (Figure 4.2). During the subsequent 10-day experimental period, energy intake was 
slightly increased in the control groups reflecting the age-related increase in body mass. In 
contrast, in the high fat diet groups, energy intake was significantly higher in the 10 days after 
the diet change compared to pre-diet change levels and also to the control groups.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Daily energy intake. Bars indicate mean energy intake per day as assessed from the 2 
weeks period on the control diet and the 10-day experimental period on the control (C █) vs. 
high fat diet (HF █). n = 8-30 (Table 4.1). *** P < 0.001 for HF vs. C. 
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4.1.3 Body fat 
The mean total body fat and its proportion to body mass are plotted in Figure 4.3. Both fat mass 
and the proportion of fat in the AKR/J high fat diet groups were significantly higher than in the 
control groups. In contrast, total fat mass and the percentage of body fat in the SWR/J high fat 
diet groups were only slightly elevated compared to the control groups, and this difference was 
not statistically significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Mean body fat (mass (g) or content (%)) on day 45 of control (C █) and high fat diet 
(HF █) in two inbred mouse strains. n = 11-12 for SWR/J and 5-6 for AKR/J. * P < 0.05, 
** P < 0.01, *** P < 0.001 for HF vs. C.  
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Individual body fat and lean mass content in relation to body mass are shown in Figure 4.3. In 
SWR/J HF and control mice, lean mass and fat mass respectively fall within the same line of 
regression. In AKR/J mice, the high fat diet group did not only have a heavier body mass and a 
lower lean mass than the control group, but also contained more fat and less lean mass at the 
same body mass, i.e., body fat content is disproportionally enlarged with body mass in AKR/J 
mice fed a high fat diet.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Individual body fat/lean mass on day 45 in two inbred mouse strains fed either 
control (C –●–) or high fat (HF –■–) diet. n = 11-12 for SWR/J and 5-6 for AKR/J. Lines 
indicate least square regression estimates for the linear relationship between body mass and fat 
or lean mass in each group.  
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4.1.4 Tissue mass 
For inguinal and retroperitoneal white adipose tissue pads, inter scapular brown adipose tissue 
pad, femoral skeletal muscle, liver and spleen, whole tissue/organ masses and their proportion 
to whole body mass are listed in Tables 4.2 and 4.3. Both the inguinal and the retroperitoneal 
white adipose tissue pads were significantly larger in the AKR/J high fat diet group than in the 
control group. Concerning these comparisons, no difference between control and HF was found 
in the SWR/J groups. In the interstrain comparison, inguinal fat mass in AKR/J control mice 
was smaller than in SWR/J mice (P<0.001), while in the HF groups there was no difference 
between AKR/J and SWR/J mice. Moreover, AKR/J mice had larger femoral muscles and 
smaller spleens than SWR/J mice. Although AKR/J mice had larger livers (mass) than SWR/J 
mice, this difference was reduced after whole body mass correction.  
 
 
 
Tissue/organ mass 
SWR/J AKR/J 
              Data  
 
Tissue C (n=11) HF (n=13) C (n=8) HF (n=9) 
White adipose tissue:  
- iWAT (mg)    
- rpWAT (mg) 
 
329.4±57.0a 
65.8±20.8 
 
372.0±110.0 
78.8±34.6 
 
219.1±47.1b 
71.6±23.3d 
 
345.3±91.0c 
147.7±36.4e 
Brown adipose tissue: 
- isBAT (mg)  
 
70.6±10.2    
 
73±10.3 
 
86.6±15.4 
 
103.6±17.2 
Skeletal muscle: 
- femoral (mg) 111.9±10.8 
 
116.1±10.0 
 
145.3±13.9 
 
155.0±15.4 
Liver (g) 1.37±0.17         1.29 ±0.10 1.50 ±0.15 1.57 ±0.17 
Spleen (mg) 101.1±11.0 102.7±12.8 55.0 ±8.0 60.4 ±1.7 
   
 
 
 
 
Table 4.2 Tissue/organ mass on day 45 in control (C) and high fat diet (HF) groups in
both SWR/J and AKR/J strains.  
Data indicate mean ± SD. Pa-b and Pd-e < 0.001, Pb-c < 0.01.  
iWAT: inguinal white adipose tissue 
rpWAT: retroperitoneal white adipose tissue 
isBAT: inter scapular brown adipose tissue 
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Tissue/organ mass (%) 
SWR/J male AKR/J male 
              Data  
 
Tissue C (n=11) HF (n=13) C (n=8) HF (n=9) 
White adipose tissue:  
- iWAT  
- rpWAT  
 
1.513±0.267a 
0.299±0.086 
 
1.690±0.418 
0.355±0.137 
 
0.904±0.148b 
0.293±0.080d 
 
1.312±0.250c 
0.560±0.093e 
Brown adipose tissue: 
- isBAT  
 
0.326±0.041 
 
0.340±0.005 
 
0.358±0.050 
 
0.396±0.044 
Skeletal muscle: 
- femoral 
 
0.516±0.059 
 
0.527±0.049 
 
0.604±0.054 
 
0.596±0.061 
Liver  6.131±0.387 5.901±0.189 6.228±0.578 6.045±0.410 
Spleen  0.465±0.043 0.467±0.065 0.228±0.017 0.234±0.011 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.3 Proportion of tissue/organ mass to whole body mass on day 45 in control (C)
and high fat diet (HF) groups in both SWR/J and AKR/J strains.  
Data indicate mean ± SD. Pa-b and Pd-e < 0.001, Pb-c < 0.01.  
iWAT: inguinal white adipose tissue 
rpWAT: retroperitoneal white adipose tissue 
isBAT: inter scapular brown adipose tissue 
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4.1.5 Litter size 
In this study, litter size was investigated in both 29 litters of SWR/J and 20 litters of AKR/J 
mice. Litter size at birth was 7±2 individuals in SWR/J mice whereas 5±2 in AKR/J mice 
(Figure 4.5). On day 21 offspring from large litters tended to be smaller than individuals from 
small litters. And the relationship between body mass and litter size is shown in Figure 4.6. The 
body mass of SWR/J mice at age of 21 days was 8.41±0.92 g, lower than SWR/J mice 
(9.50±2.34 g). The variation of body mass in small litter size was higher. To exclude this 
influence, only mice from large litters (>5) were selected for the further experiment.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 frequency distribution of litter size in two inbred mouse stains. Bars indicate the 
number of litters in corresponding litter sizes in SWR/J and AKR/J mice.  
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Figure 4.6 The relationship between body mass (day 21) and litter size in two inbred mouse 
strains. The inverse relation is shown in both strains with r2=0.86 in SWR/J and 0.75 in AKR/J 
mice. 
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4.2 Gene expression study 
The in vivo feeding experiments confirmed that in comparison to AKR/J mice, SWR/J mice 
were resistant to high fat diet feeding in terms of body mass increase and adiposity (body fat 
content). Using array (filter and chip) technology, it was investigated whether these phenotypic 
differences between strains were associated with differential gene expression in the 
hypothalamus. 
 
4.2.1 Data analysis I  
4.2.1.1 Array hybridization 
The numbers of selected candidate genes from the first set of filter complex hybridizations are 
listed in Table 4.3. there were more differentially expressed genes found in the inter-strain 
comparison than in the intra-strain diet comparison, i.e., the impact of genetic background 
(strain) on differential gene expression appeared to be larger than the diet effect.  
 
 
Comparison group Number of candidates 
AKR/J Control vs. HF 10 
SWR/J Control vs. HF 13 
Control AKR/J vs. SWR/J 60 
HF AKR/J vs. SWR/J 28 
 
Focused on the diet related genes, the fold changes in SWR/J gene expression were larger than 
in AKR/J. The candidate genes regulated by different diet within either AKR/J or SWR/J strain 
are shown in Table 4.4 and 4.5. The candidate genes in the inter strain comparison are shown in 
Appendix.  
 
 
 
 
 
Table 4.3 Number of candidate genes in different comparison groups identified from data 
analysis I. 
  Results 
 
 51
Table 4.4 List of candidate genes regulated by diet in AKR/J mice from data analysis I. 
AKR/J 
RZPD clone ID 
GenBank 
accession 
number 
Cluster description by RZPD Fold 
changea 
IMAGp952A0616 aa030182, 
ai323327, 
ai894083 
SRY-box containing gene 3 2.68 
IMAGp952A0534 aa289979, 
ai661640 
ribosomal protein L21 2.55 
IMAGp952I2410 ai413755, 
ai425782, 
w80260 
chaperonin subunit 3 (gamma) 2.26 
IMAGp952F0922 aa119175 serine/threonine kinase 19 2.17 
IMAGp952D0658 ai226511, 
ai266811 
ornithine transcarbamylase 2.12 
IMAGp952O0249 aa673382 mitogen-activated protein kinase kinase 
kinase kinase 6 
2.84 
IMAGp952F0432 aa272827 wingless-related MMTV integration site 
11 
-2.34 
IMAGp952P1311 w97066 transgelin 2.32 
IMAGp952A1121 aa086944, 
ai595208 
ESTs, Weakly similar to S55051 Bicaudal-
C - fruit fly [D.melanogaster] 
-2.29 
IMAGp952H1522 aa119208 M.musculus mRNA for e1 protein 2.10 
a: positive means upregulated in HF group while negative means downregulated 
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Table 4.5 List of candidate genes regulated by diet in SWR/J mice from data analysis I. 
RZPD clone ID  GenBank 
accession 
number 
Cluster description by RZPD Fold 
changea 
IMAGp952C1431 aa048282 ESTs, Highly similar to T17338 
hypothetical protein DKFZp434O125.1 - 
human [H.sapiens] 
13.59 
IMAGp952F2058 ai226516, 
ai266816 
transthyretin 10.16 
IMAGp952F0714 aa011728 ESTs, Weakly similar to KIAA0672 
protein [H.sapiens] 
10.07 
IMAGp952J1319 aa049077 ESTs, Weakly similar to AF161429_1 
HSPC311 [H.sapiens] 
9.16 
IMAGp952N1531 aa060121 Down syndrome critical region homolog 2 
(human) 
8.76 
IMAGp952E149 w71639 ESTs, Weakly similar to matrin cyclophilin 
[R.norvegicus] 
4.02 
IMAGp952L0560 ai227481 programmed cell death 4 -3.36 
IMAGp952B1828 aa267461 ESTs, Weakly similar to TIG1_human 
retinoic acid receptor responder protein 1 
[H.sapiens] 
2.81 
IMAGp952L1821 aa117451 ESTs, Weakly similar to y+L amino acid 
transporter 1 [R.norvegicus] 
-2.62 
IMAGp952K0127 aa168457 ESTs, Weakly similar to ZIP-kinase 
[M.musculus] 
2.59 
IMAGp952L1859 ai117643, 
ai151964 
ESTs, Moderately  similar to glucose 
inhibited division protein A [Pseudomonas 
putida] 
2.51 
IMAGp952A245 w41629 ESTs, Highly  similar to NADH-
ubiquinone oxidoreductase SGDH subunit 
precursor [Bos taurus] 
2.51 
IMAGp952A1547 aa547134, 
ai505917 
baculoviral IAP repeat-containing 6 2.50 
a: positive means upregulated in HF group while negative means downregulated 
 
IMAGp952F2058 (Transthyretin, TTR) was found in the comparisons of SWR/J Control vs. 
HF and HF SWR/J vs. AKR/J (Appendix 2), and it was shown upregulated >10 fold by high fat 
diet.  
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4.2.1.2 Visual inspection of the filter array image  
Each filter image was analyzed using ArrayVision software. All of the candidate genes selected 
in data analysis I (Table 4.4 and 4.5) were checked to find whether the expression image was 
affected by neighbor spots, dirt or other biasing effects. Each candidate (in duplicate) was 
circled both in the control and the HF filter, and the result of the filter image inspection 
(intensity) was consistent with the data analysis result. Examples are given in Figure 4.7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 Filter image inspections of IMAGp952 O2034, F2058, C1431, F0714, J1319 and 
N1531. The candidate (in duplicate) was circled both in the control and the HF filter. 
AKR/J C AKR/J HF
IMAGp952O2034
SWR/J C SWR/J HF
IMAGp952F2058 
SWR/J SWR/J HFC 
IMAGp952C1431
SWR/J C SWR/J HF
IMAGp952F0714 
SWR/J HF
IMAGp952J1319
SWR/J C SWR/J C SWR/J HF
IMAGp952N1531 
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4.2.1.3 Northern blot analysis 
Two candidates, one from AKR/J Ctrl vs. HF – IMAGp952O2034 (aa289615) and the other 
one from SWR/J control vs. HF – IMAGp952F2058 (Transthyretin, TTR) were tested on 
Northern blot analysis loaded with the same RNA as used in the cDNA synthesis for the filter 
hybridization.  
On the filter, IMAGp952O2034 (aa289615) was two fold upregulated in AKR/J HF compared 
with AKR/J control. However, this result was not confirmed on Northern blot analysis (Figure 
4.8). IMAGp952F2058 (Transthyretin, TTR) was > 10 fold upregulated in SWR/J HF 
compared with SWR/J control but not in AKR/J mice, and this finding was confirmed on 
Northern blot analysis (Figure 4.9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 IMAGp952O2034 in Northern blot (right) loaded with the same pooled RNA
samples as used in the cDNA syntheses for the filter hybridizations. The left is the RNA gel
(ethidium bromide staining) used for Northern blotting.  
Figure 4.9 IMAGp952F2058 in Northern blot (right) loaded with the same pooled RNA
samples as used in the cDNA syntheses for the filter hybridizations. The left is the RNA gel
(ethidium bromide staining) used for Northern blotting. 
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Northern blots loaded with 16 different individual RNA samples were used for further testing 
of these two candidates. Whereas IMAGp952O2034 (aa289615) (Figure 4.10) was again not 
confirmed. The expression of IMAGp952F2058 (Transthyretin, TTR) showed a marked 
variation in different RNA samples (Figure 4.11).  
 
 
 
  
 
 
 
  
 
 
 
 
 
 
Figure 4.10 Northern blot analysis (with new RNA samples) of IMAGp952O2034. Each lane 
contains RNA from 4 individual SWR/J or AKR/J mice fed either the control (C1-C4) or the 
high fat (HF1-HF4) diet. The upper is the RNA gel (ethidium bromide staining) used for 
Northern blotting. 
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Figure 4.11 Northern blot analysis (with new RNA samples) of IMAGp952F2058. Each lane 
contains RNA from 4 individual SWR/J or AKR/J mice fed either the control (C1-C4) or the 
high fat (HF1-HF4) diet. The upper is the RNA gel (ethidium bromide staining) used for 
Northern blotting. 
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Another 4 candidates with high fold changes (8 to 13) from SWR/J Ctrl vs. HF were tested by 
Northern blot analysis (Figure 4.12). The expression patterns were similar to TTR.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12 Northern blot analyses (with new RNA samples) of 4 different candidates from 
SWR/J control vs. HF. Each lane contains RNA from 4 individual SWR/J or AKR/J mice fed 
either the control (C1-C4) or the high fat (HF1-HF4) diet, or the same pooled RNA samples as 
used in the cDNA syntheses for the filter hybridizations (C or HF).  
SWR/J AKR/JC1431
C1 C2 C3 C4 C1 C2 C3 C4HF1 HF2 HF3 HF4 HF1 HF2 HF3 HF4C CHF HF
SWR/J AKR/JF0714
C1 C2 C3 C4 C1 C2 C3 C4HF1 HF2 HF3 HF4 HF1 HF2 HF3 HF4C CHF HF
SWR/J AKR/JN1531
C1 C2 C3 C4 C1 C2 C3 C4HF1 HF2 HF3 HF4 HF1 HF2 HF3 HF4C CHF HF
C1 C2 C3 C4 C1 C2 C3 C4HF1 HF2 HF3 HF4 HF1 HF2 HF3 HF4C CHF HF
J1319SWR/J AKR/J
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4.2.1.4 Sequencing 
In Table 4.6 the sequencing results of the 6 candidates tested by Northern blot analysis are 
listed. In RZPD database, these 6 candidates were named differently with different description. 
However the sequencing results showed that 5 out of the 6 candidates tested are TTR.    
 
     Table 4.6 The sequencing results of the 6 candidates tested by Northern blot analysis. 
Northern blot 
analysis 
RZPD clone ID  RZPD description Blast results 
with 
commercial 
sequencing  
Original 
RNA 
Pool 
New RNA 
from 
individual 
mouse 
IMAGp952O2034 aa289615, EST aa289615, EST negative negative 
IMAGp952F2058 Transthyretin Transthyretin positive negative 
IMAGp952C1431 ESTs, Highly similar to 
T17338 hypothetical 
Protein 
Transthyretin positive negative 
IMAGp952F0714 ESTs, Weakly similar to 
KIAA0672 protein 
Transthyretin positive negative 
IMAGp952J1319 ESTs, Weakly similar to 
AF161429_1 HSPC311 
Transthyretin positive negative 
IMAGp952N1531 Down syndrome critical 
region homolog 2 
Transthyretin positive negative 
    Negative: the result of Northern blot analysis is not consistent with filter result. 
    Positive: the result of Northern blot analysis is consistent with filter result. 
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4.2.1.5 In Situ hybridization 
In Situ hybridization (Figure 4.13) showed that Transthyretin (TTR) is localized out side of the 
hypothalamus – dosal 3rd ventricle and the lateral ventricle, both in AKR/J and SWR/J mice. 
 
 
 
 
 
 
 
 
 
 
 
 
4.2.2 Data analysis II 
4.2.2.1 Array hybridization  
The 17 selected candidates are listed in Table 4.7 and 4.8. The majority of candidates (13 out of 
17) emerged from the interstrain comparison.  
 
  
Comparison group Number of candidates 
AKR/J Control vs. HF 2 
SWR/J Control vs. HF 2 
Control AKR/J vs. SWR/J 10 
HF AKR/J vs. SWR/J 3 
 
 
 
 
Figure 4.13 Representative in situ hybridization image demonstrating the
expression of TTR (trsnsthyretin) in the mouse brain. A section from an AKR/J /
SWR/J muse is shown. The hypothalamus is circled.  
Table 4.7 Number of candidates in different comparison groups from data analysis II 
Lateral ventricle 
Dorsal 3rd ventricle
  hypothalamus
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Table 4.8 List of candidates from data analysis II (Part I-IV) 
 
Part I – AKR/J control vs. HF: 
GenBank 
accession 
number 
RZPD 
Clone ID 
Affy ID Blast result Filter 
fold 
changea 
Chip 
fold 
changea
ai119403, 
ai131627 
IMAGp952
J2454 
93797_g_at Atp1a1 ATPase, Na+/K+ 
transporting, alpha 1 
polypeptide 
-1.80  1.25 
w91276 IMAGp952
B0812 
160289_s_at Mm.29482, 1110019C08Rik -2.04 -1.14 
a: positive means upregulated in the HF group while negative means downregulated  
 
Part II – SWR/J control vs. HF: 
GenBank 
accession 
number 
RZPD 
Clone ID 
Affy ID Blast result Filter 
fold 
changea 
Chip 
fold 
changea
ai196320 IMAGp952
J0157 
162274_f_at Lisch7-pending liver-specific 
bHLH-Zip transcription 
factor 
-2.10 -1.27 
aa607542 IMAGp952
L2249 
97989_at similar to gb:M29551 protein 
phosphatase 2b, catalytic 
subunit 2 (human); mRNA 
sequence 
 2.15  1.16 
a: positive means upregulated in the HF group while negative means downregulated 
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Part III – AKR/J control vs. SWR/J control: 
GenBank 
accession 
number 
RZPD Clone ID Affy ID Blast result Filter 
fold 
changea 
Chip 
fold 
changea
aa413119 IMAGp952A1740 93721_at Cap1 adenylyl 
cyclase-associated 
CAP protein homolog 
1 (S. cerevisiae, S. 
pombe) 
 2.03  1.32 
aa036456, 
ai323372, 
ai325380 
IMAGp952H2117 93630_at CUGBP1 CUG triplet 
repeat, RNA binding 
protein 1 
-2.07 -1.20 
aa009082 IMAGp952C2231 94522_at Dctn3 dynactin 3 -2.02 -1.36 
w75791 IMAGp952L059 98525_f_at similar to edr erythroid 
differentiation 
regulator  
 2.39  4.29 
aa475583 IMAGp952K0643 100494_at Fgf1 fibroblast growth 
factor 1 
-2.44 -1.20 
ai097693, 
ai118254 
 
ai119514, 
ai158857 
IMAGp952J2356 
 
 
IMAGp952K1155 
93269_at 
 
 
93269_at 
Glo1 glyoxalase 1 -2.44 
 
 
-2.11 
-1.88 
 
 
-1.88 
 
ai196289, 
ai196587 
  
IMAGp952P0557 
 
  
 93269_at 
   
-2.58 
 
-1.88 
      
ai413558, 
“w34034” 
IMAGp952B243 162457_f_at Hba- α1 hemoglobin 
alpha, adult chain 1 
 2.01  1.64 
aa052364 IMAGp952H105 96667_at Mm.7418, Ppp2cb 
protein phosphatase 
2a, catalytic subunit, 
beta isoform 
 2.23  1.32 
aa473963 IMAGp952A2437 95508_at Nckap1 NCK-
associated protein 1 
-2.02 -1.65 
aa509365 IMAGp952L2441 101024_i_at Skp1a S-phase kinase-
associated protein 1A 
-2.65 -1.32 
a: positive means upregulated in the SWR/J group while negative means downregulated 
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Part IV – AKR/J HF vs. SWR/J HF: 
GenBank 
accession 
number 
RZPD 
Clone ID 
Affy ID Blast result Filter 
fold 
changea 
Chip 
fold 
changea
w97978 IMAGp952
L0912 
101102_at Igbp1 immunoglobulin 
binding protein 1 
 3.76  1.22 
aa146387, 
ai326750, 
ai528541 
IMAGp952
P2126 
162137_f_at Txk TXK tyrosine kinase -2.48 -1.16 
aa030192, 
ai430809, 
ai509123 
IMAGp952
O0316 
102002_at Ubqln2 ubiquilin 2  2.23  1.24 
a: positive means upregulated in the SWR/J group while negative means downregulated 
 
From this list, Hba-α1 and Glo1 were selected according to the fold change in filter and chip for 
further experiments. Although the fold change of candidate edr (w75791) is high in both arrays 
the blast result is not satisfactory so that it was not selected. 
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4.2.2.2 Visual inspection of the filter array image  
The expression patterns of Hba-α1 (hemoglobin alpha, adult; IMAGp952B243) and Glo1 
(glyoxalase 1; IMAGp952J2356, K1155 and P0557) were confirmed by filter image inspections 
(Figure 4.14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14 Filter image inspections of IMAGp952B243, P0577, J2356 and K1155. The 
candidate (in duplicate) was circled both in SWR/J and AKR/J control filter. 
 
 
 
 
 
 
 
 
SWR/J C  AKR/J C 
IMAGp952B243
SWR/J C AKR/J C 
IMAGp952P0577 
SWR/J C AKR/J C 
IMAGp952J2356
SWR/J C AKR/J C 
IMAGp952K1155 
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4.2.2.3 Northern blot analysis of Glo1 
The higher array Glo1 RNA expression level in AKR/J mice was confirmed by Northern blot 
analysis (Figure 4.15). Within strains, there was no difference in Glo1 expression, i.e., Glo1 
was not affected by diet. Because of sample limitation, only Glo1 was tested on Northern blot 
analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15 Hypothalamic Glo1 mRNA expression in individual SWR/J and AKR/J mice fed 
either control or HF diet (n = 5 per group). Bars indicate the expression of relative signal 
intensity of each band. Data indicate signal intensity mean ± SD for each group. The difference 
in Glo1 expression between strains is significant (P< 0.001), but not within strains.       
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4.2.2.4 PCR 
PCR was performed with gene-specific primers designed for 8 selected candidates. Only one 
was consistent with the array result (Ppp2cb) but the difference was not significant and the fold 
change (1.16 in PCR) was lower than in array (2.15 in filter and 1.16 in chip). Two candidate 
genes showed regulation in the opposite direction and five showed high individual variation but 
no systematic effect of strain or diet. Glo1 was not confirmed in this normal RT-PCR, however, 
it was confirmed in real time RT-PCR.  
 
 
 
 
 
 
 
 
Figure 4.16 RT-PCR analysis of candidates selected from array data analysis II. Band intensity 
was analyzed by Image station (Kodak).  Glo1 showed slightly downregulated in ac compared 
with sc. Ppp2cb was consistent with the array result, but the fold change is lower in PCR (1.16) 
and the difference was not significant. ac: AKR/J control, sc: SWR/J control, ah: AKR/J high 
fat, sh: SWR/J high fat. 
 
 
 
 
 
 
 
 
 
 Ladder ac1 ac2  ah1  ah2   sc1  sc2   sh1  sh2 
Intensity102 129  138  143   138   143   142  134 
Glo1
 sc1  sc2   sh1 sh2 
 99  114   125  123 
Ppp2cb  
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4.2.2.5 In Situ hybridization 
In Situ hybridization of Hba-α1 (Figure 4.17) showed that the expression of Hba-α1 is not 
restricted to the hypothalamus but the signals are almost randomly distributed all over the brain. 
A hotspot of Hba-α1 expression appears to be in the region of dorsal 3rd ventrile and supraoptic 
nucleus. In general SWR/J mice have a higher Hba-α1 expression than AKR/J both inside and 
outside the hypothalamus. In contrast, Glo1 shows a very district pattern of expression 
preferably in the hippocampus (Figure 4.18). In the hypothalamus, Glo1 expression indicates in 
the arcuate nucleus (ARC), ventromedial hypothalamic nucleus (VMH) and paraventricular 
hypothalamic nucleus (PVN). Whereas the expression of Glo1 outside the hypothalamus is 
similar in both strains, Glo1 mRNA expression in the hypothalamus is much stronger in AKR/J 
compared to SWR/J mice. In situ hybridization therefore qualitatively confirms the results by 
array experiments with respect to Glo1 and Hba-α1.  
 
 
Figure 4.17 Representative image of Hba-α1 mRNA expression in the mouse brain by in situ 
hybridization. Hba-α1 is distributed all over the brain and its overall expression is higher in 
SWR/J than in AKR/J mice. D3V: dosal 3rd ventricle, Hypo.: hypothalamus, SON: supraoptic 
nucleus.  
Hypo.
SON
D3V
AKR/J C SWR/J C
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Figure 4.18 Representative image of Glo1 mRNA expression in the mouse brain by in situ 
hybridization. In the hypothalamus, Glo1 is expressed in the ARC, VMH and PVN, and its 
hypothalamic expression is higher in AKR/J compared to SWR/J mice.  
 
 
4.2.2.6 Alignment of hemoglobin and neuroglobin gene sequences 
Hemoglobin in the erythrocyte is produced from bone marrow. It is surprising to find 
hemoglobin expressed in the brain. There are several members in the globin family – 
hemoglobin, myoglobin and neuroglobin. To check the similarity of sequences between 
neuroglobin (which localizes in the brain) and hemoglobin probe which was used for in situ 
hybridization, alignment analysis was carried out and it showed only 42% similarity (Figure 
4.19).  
 
SWR/J CAKR/J C
Hippocampus
D3V 
Thalamus
PVN
ARC
VMH
  Results 
 
 68
 
Figure 4.19 Sequence alignment of neuroglobin and hemoglobin probe which was used for in 
situ hybridization. Positions with identical nucleotides are drawn against a black background. 
Dashes represent deletions in the sequence of haemoglobin relative to neuroglobin.  
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4.2.3 Data analysis III  
Focused on diet induced genes, new candidates were selected only from filter data and then 11 
clones were ordered from RZPD.  5 of them were verified in Northern blot analysis but only 
one was confirmed (Table 4.9), which was also confirmed in the filter image inspection (Figure 
4.20). Only the positive Northern blot is shown in Figure 4.21, other blots not shown. 
 
Table 4.9 list of data analysis III 
GenBank 
accession 
number 
 RZPD Clone ID Comparison 
groupa 
 Blast result Fold 
changeb 
Northern 
blot 
analysisc 
aa451138, 
ai481012 
IMAGp952A0241 ACH high mobility group AT-hook 
2, pseudogene 1 
-2.16  
aa051449 IMAGp952J2019 ACH intestinal cell kinase -1.99 N 
aa451434 IMAGp952G1341 ACH map2k7 mitogen activated 
protein kinase kinase 7 
-1.52  
aa869362 IMAGp952A1851 ACH tumor necrosis factor, alpha-
induced protein 1 (endothelial) 
 1.97 P 
w41719 IMAGp952B225 SCH asparaginyl-tRNA synthetase -2.28  
aa511409 IMAGp952D2441 SCH glutaminase  -2.73 O 
ai385680, 
ai893963, 
w79980 
IMAGp952M2410 SCH GPC4 glypican 4 -3.80 N 
aa537148 IMAGp952A1947 SCH laminin, alpha 5  -2.61 O 
aa269563 IMAGp952C0733 SCH RIKEN hypothetical protein -3.75  
aa546545 IMAGp952C2147 SCH Thrap6-thyroid hormone 
receptor associated protein 6 
or hypothetical protein 
-2.09  
aa451295 IMAGp952A1941 SCH ubiquitin-like 3  -2.71  
a: ACH means AKR/J control vs. HF; SCH means SWR/J control vs. HF 
b: negative means downregulated in HF 
c: N means no difference between two groups; P means positive; O means not detectable.  
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Figure 4.20 Filter image inspection of TNFAIP1. The candidate (in duplicate) was circled both 
in control and HF filter.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.21 TNFAIP1 mRNA expression in individual SWR/J and AKR/J mice fed either 
control or HF diet (n = 3-4 per group). Bars indicate the relative signal intensity of each band 
and the data indicate signal intensity mean ± SD for each group. There is a significant 
difference in TNFAIP1 expression between HF and control mice in AKR/J, but not in SWR/J.  
 
In Situ hybridization shows that TNFAIP1 localizes in the arcuate nucleus, the ventromedial 
hypothalamic nucleus and the paraventricular hypothalamic nucleus (Figure 4.22). 
Quantification of TNFAIP1 expression in the hypothalamic region was performed using 
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Image-Pro Plus (Media Cybernetics). Although it showed 1.6 fold upregulation in the ARC by 
high fat diet, this difference was not significant because of the individual variation (Figure 
4.22), further experiment with more samples should be carried out to confirm this conclusion. 
 
                                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.22 representative image of TNFAIP1 mRNA expression in the mouse brain by in situ 
hybridization and its quantification analysis. In the hypothalamus, TNFAIP1 is expressed the 
ARC, VMH and PVN. Bars indicate relative signal intensity of TNFAIP1 expression in each 
hypothalamus. ac: AKR/J control, ah: AKR/J high fat. 
PVN 
AKR/J HFAKR/J C
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4.2.4 Real-time RT-PCR 
A real-time RT-PCR trace for 32 wells on a 96-well plate is shown in Figure 4.23.  The 
threshold was defined by the software in the region associated with an exponential growth of 
PCR product. The point at which the fluorescence crosses the threshold is called the Ct value 
which is inversely proportional to the logarithm value of starting amount of target DNA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.23 A real-time RT-PCR trace for 32 wells on a 96-well plate. Cycles are shown along 
the X-axis, and background corrected arbitrary fluorescence units are shown on the Y-axis. The 
real-time RT-PCR traces are indicated with different colors. The orange horizontal line 
indicates the threshold.  CF RFU: curve fit relative fluorescence units; Ct: threshold cycle. 
 
The real-time RT-PCR standard curve is shown in Figure 4.24. The standard curve is generated 
from a dilution series (1, 1:4, 1:16, 1:64) of cDNA. From the standard curve, PCR efficiency 
was calculated and relative values for the respective target gene in each experimental and 
control sample were extrapolated.  
 
 
 
 
 
Threshold 
Ct
  Results 
 
 73
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.24 Real-time RT-PCR standard curve. Cycles (   ) indicate the duplicates of 4 dilutions 
(1, 1:4, 1:16, 1:64) and squares (    ) indicate the duplicates of unknown samples.  
 
Four candidate genes were tested in real-time RT-PCR. The relative value was the normalized 
data which was derived from the mean of target gene starting quantity (SQ) divided by the 
mean of corresponding beta actin SQ. However, only strain specific genes – Glo1 and Hba-α1 
were found significantly differentially expressed between strains. No significant difference was 
found for diet-induced genes – Ppp2cb and TNFAIP1 between the control and high fat diet 
groups within strains (Figure 4.25).  
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Standard  gene
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Figure 4.25 Real-time RT-PCR analyses of 4 candidate genes.  Bars indicate relative value of 
candidate gene in individual animal sample. Strain specific genes – Glo1 and Hba-α1 were 
found significantly differentially expressed between strains, whereas diet-induced genes – 
Ppp2cb and TNFAIP1 were found no difference within strains. Pa2-b2 < 0.05, Pa-b< 0.01, 
Pa1-b1and Pc-d < 0.001. sc: SWR/J control, sh: SWR/J high fat, ac: AKR/J control, ah: AKR/J 
high fat. 
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4.3 SNP analysis of gene Glo1 
Kathrin Reichwald (IMB, Jena) resequenced the Glo1 gene and revealed several sequence 
variations in non-coding and coding regions by SNP analysis (Table 4.10). The reference DNA 
sequence (rc.mm.Glo1.genomic.040120, 24665 bp) used in SNP analysis consists of 19665 bp 
of Glo1 gene and twice 2500 bp of upstream and down stream sequences. Furthermore, the 
online program – MatchTM at www.gene-regulation.com was used to search different potential 
binding sites for transcription factors due to the single nucleotide polymorphism between 
AKR/J and SWR/J strains. Some transcription factor binding sites are changed by the 
nucleotide exchange, which is shown different between these strains.  
 
Table 4.10 SNP analysis of Glo1 gene in AKR/J and SWR/J 
 5’ upstream region Exon 1 Intron 1 Exon3 Intron 5 
Position in 
the genomic 
DNA 
858 925 1057 1374 1601 2158 2485 2732 14878 14882 18737 20730
Sequence in 
reference 
DNA  
C A M G A C G A T G G G 
Sequence in 
AKR/J 
M M M AA AA C/T GG AA CC GG GG TT 
Position in  
AKR/J 
sequence 
857 923 1055 1372 1599 2156 2483 2730 14876 14880 18735 20728
Sequence in 
SWR/J 
M M CC GG M CC CC TT CC AA AA TT 
Position in  
SWR/J 
sequence 
857 923 1056 1373 1599 2156 2483 2730 14876 14880 18735 20728
Transcription 
factor bound 
ND ND ND ND ND B1 ND B2 ND B3 B4 ND 
M: insertion or deletion; AA: homozygote; CT: heterozygote; ND: no difference; B1: T bind s 
c-Ets-1(p54) and FOXD3; B2: A binds CHOP-C/EBPalpha; B3: G binds GATA-1, -2 and -X; 
B4: G binds HNF-4 and Oct-1, A binds HNF-1 and Pax-4. 
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5 Discussion  
5.1 Diet experiment 
In this study, two different diets – a standard control diet and a high fat diet, and two different 
inbred mouse strains –AKR/J and SWR/J – were applied to investigate the effect of diet-
induced obesity on hypothalamus gene expression. The energy from the high fat diet is mainly 
derived from fat, whereas > 50% of the energy in the control diet comes from carbohydrates. 
AKR/J and SWR/J mice represent a useful model for diet research because of their differential 
response to HF feeding. AKR/J mice prefer HF and are prone to obesity, and on the contrary, 
SWR/J mice prefer carbohydrates and are obesity resistant. (Bachmanov et al., 2002;Prpic et 
al., 2002;Smith et al., 1997;Smith et al., 1999;Smith et al., 2000;Smith et al., 2001).  
 
5.1.1 Body mass and body fat 
On given the high fat diet, AKR/J mice increased their body mass rapidly within the first 1-2 
days, after which, body mass increased at a stable level, similar to control mice. After 10 days 
on the diet experiment, both female and male AKR/J mice fed the high fat diet were 
significantly heavier than the control groups. In contrast, SWR/J mice showed no difference in 
body mass between the high fat diet and the control groups (Figure 4.1).  
Not only body mass but also body fat (body fat mass and body fat percentage) in the AKR/J 
high fat groups was higher than in the control groups (Figure 4.3). Compared with the control 
group, the AKR/J high fat diet group had lighter body lean mass (Figure 4.4). This suggests that 
the increase of body mass in AKR/J high fat diet feeding group was primarily due to an 
increase in body fat content, This was reflected in the white adipose tissue depots (inguinal and 
retroperitoneal), which were larger in the AKR/J high fat groups compared with the control 
groups. Similar results were obtained by Prpic et al. in a 4-week high fat diet experiment (Prpic 
et al., 2002) and also by West et al. in a 7-week high fat diet experiment (West et al., 1992). 
Moreover, fat distribution also showed difference between strains. Originally, AKR/J mice had 
smaller inguinal fat pad and similar retroperitoneal fat pad compared with SWR/J mice. After 
10 days on high fat diet, because both were significantly increased only in AKR/J mice, 
inguinal fat pad became similar in two strains and retroperitoneal fat pad was larger in AKR/J 
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than in SWR/J mice. The difference of regional fat distribution may also a phenotype in DIO 
model.  
 
5.1.2 Energy intake  
In the present 10-day diet experiment, energy intake in both strains was significantly higher in 
the high fat diet groups than in the control groups (Figure 4.2), which is consistent with the 
report of Smith et al. (Smith et al., 1999), but is different from the results shown in other 
studies where only AKR/J mice exposed to high fat diet took more energy but not SWR/J mice 
(Prpic et al., 2002;West et al., 1992).  
The reason for this difference could be the different exposure time to high fat diet feeding. 
Ziotopoulou et al. reported that significant difference of energy intake between high fat and low 
fat feeding groups appeared on day 2 but disappeared on day 7, and then again appeared on day 
14 (Ziotopoulou et al., 2000). This was also supported by West et al., who reported that some 
high fat diet groups consumed significantly more energy than the controls only in the first week 
but not in the following 7 weeks (West et al., 1992). It is also possible that the behavior of the 
same mouse strain in different laboratories is different even if the equipment, test protocols and 
many environmental variables are rigorously standardized (Crabbe et al., 1999).  
 
5.1.3 Energy expenditure 
Different genetic background results in the different phenotype between these two strains. The 
observation that the high fat groups in both SWR/J and AKR/J strains consumed more energy 
but only AKR/J mice became obese suggests that SWR/J mice may be able to increase their 
energy expenditure and thereby counterbalance obesity when confronted with HF feeding 
supplies. In agreement, Wahlsten et al. reported that SWR/J mice were particularly difficult to 
handle and much wilder than AKR/J mice (Wahlsten et al., 2003). Moreover, this hypothesis is 
also supported by West et al. who measured energy expenditure by doubly labeled water and 
found that energy expenditure per mouse was higher in SWR/J than in AKRJ mice (West et al., 
1994). In another study, AKR/J mice ate more than SWR/J mice when using the unadjusted 
daily food intake (g/mouse), on the contrary, when the adjusted daily food intake related to 
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body mass (g/30g body mass) was calculated, SWR/J mice consumed more (Bachmanov et al., 
2002), because AKR/J mice are heavier.  Konarzewski and Diamond measured basal metabolic 
rate (BMR) in AKR/J and SWR/J mice and showed no difference (Konarzewski & Diamond, 
1995), however, because AKR/J mice are heavier, SWR/J consumed more oxygen.  
 
5.1.4 Litter size 
In this study, SWR/J mice had a higher breeding performance than AKR/J mice (www.jax.org; 
(Osman et al., 1997) and litter size in SWR/J (7.7 ± 1.8) was larger than in AKR/J mice (5.7 ± 
2.4). The smaller litter size caused heavier body masses on day 21 in AKR/J (9.50 ± 2.34 g) 
than in SWR/J mice (8.41 ± 0.92 g) (Figure 4.5). In agreement, Epstein reported the inverse 
relation between litter size and body mass (Epstein, 1978). This may be a point to help us to 
understand why AKR/J is prone to obese. It was reported that animals (mice, rats and rabbits) 
in small litters were heavier and gained more rapidly than animals in large litters (Roberts et al., 
1988;Cryer & Jones, 1980;Rommers et al., 2001). 
 
5.2 Gene expression profiling 
5.2.1 Normalization  
The RZPD filter hybridization was made twice with the same sample from each group to check 
reproducibility of the results. Because of the difference in radioactive labelling efficiency, 
cDNA filter quality, and exposure time, raw data can not be compared and therefore a 
normalization procedure is required. Different normalization methods have been developed and 
discussed since array technology is used more and more widely. For instance, the MAS 5.0 
Statistical algorithm from Affymetrix (www.affymetrix.com, 2001), intensity-dependent 
normalization (Yang et al., 2002),  non-linear normalization (Workman et al., 2002), and so on. 
The advantage and disadvantage of different methods have been still in discussion. After 
comparison, the latest published quantile normalization (Bolstad et al., 2003) was performed 
for the whole set of filter data to reduce technical bias between filters (Figure 5.1). For chip 
data, the same normalization procedure was applied. After normalization it is possible to make 
the following quantitative comparisons of signal intensities between filters and chips 
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respectively: SWR/J control vs. HF, AKR/J control vs. HF, SWR/J control vs. AKR/J control, 
and SWR/J HF vs. AKR/J HF.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Quantile normalization. The x- and y-axes indicate the intensity of individual spots 
from filters 132 and 136 respectively, which in this example were both hybridized with the 
same probe from SWR/J control mice. The solid straight line in each plot represents the line of 
equality of signal intensity. 
 
5.2.2 Candidate selection criteria 
Although the fold change is the most important factor for the differentially expressed gene, the 
candidate selection must go through several criteria including it because all of others can affect 
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it. The candidate selection procedure was based on the following criteria: M value (indicates 
fold change of signal intensity between comparison groups), A value (indicates intensity), 
standard deviation of duplicates within array and of the same candidate gene between arrays, 
and z-scores of signal intensity between comparison groups. The MA plot is first described by 
Dudoit et al. (Dudoit et al., 2002) and widely applied in array data analysis. The M value is a 
quantitative measure for the between-group difference in signal intensity of a specific gene 
spot. However, M values are not independent of absolute signal intensity: for low intensities, M 
values are not reliable because technical variance such as background or neighbouring spots can 
produce large effects, which have no biological significance. Therefore, genes with low M 
values, or even high M values but with low A values were removed from the candidate lists. By 
checking z-scores, most of the genes with relative high M value but in the range of low 
intensity were also eliminated. In addition, differences in spot intensity of each duplicate gene 
within arrays and between arrays was calculated, and only the genes which exhibited low 
differences were short-listed for further analysis.  
 
5.2.3 RZPD high density cDNA Filters and Affymetrix GeneChips 
A filter is an array of clones printed on nylon membrane while a chip is an array of 
oligonucleotides (25-mers) that are synthesized in a photolithographic process directly onto 
chip's surface (glass) at very high density. Filters are hybridized to radioactive labelled cDNA 
synthesized from RNA, while chips are hybridized to biotin-labelled cRNA generated via 
cDNA from RNA. Compared with chips, filters are cheaper and can be reused up to 10 times. 
The disadvantage is that there are 20-30% false spots (telephone communication with RZPD) 
on the filters of the first generation (used in this study), i.e., 20 –30% of clones spotted on a 
filter do not match the gene description supplied by the RZPD. Therefore, the original spotted 
clones of the candidates selected must be sequenced for confirmation. This shortage is now 
overcome in the product of the second generation: all clones are sequenced before they are 
spotted onto the filters. In this gene expression study, it shows that filters are more sensitive 
than chips, because the fold change of the same gene in the filter is higher than in the chip, but 
the variation in filter is also higher than in chip. The optimal method would be to combine these 
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two technologies. In summary, filters appear to be more sensitive at the detection of small 
effects than filters.  
 
5.2.4 Validation of candidate genes from array analysis  
There are a variety of methods for the validation of candidate genes selected from array 
analysis. These include: Northern blot analysis, in situ hybridization, traditional RT-PCR and 
real-time RT-PCR. However, not all of the candidates from array analysis can be validated in 
other methods. Using real-time RT-PCR Mutch et al. examined 27 candidates selected from 
microarray data and found a concordance of 77.7% (Mutch et al., 2002). Similar results (71%) 
were reported by Rajeevan et al. in a validation study of array-based gene expression profiles 
by real-time RT-PCR using the candidates with more than twofold difference (Rajeevan et al., 
2001b;Rajeevan et al., 2001a). In this study, 3 of 10 genes from the array analysis were 
confirmed by Northern blot analysis, 3 of 4 were confirmed by in situ hybridization, and 2 of 4 
by real-time RT-PCR. All of these methods worked well, however, there are some difference. 
Northern blot is the most widely used method in most laboratories, but it requires quite much 
RNA. Although in situ hybridization is the most complicated method it can be used not only for 
the investigation of expression but also for the localization. Real-time RT-PCR is relative 
convenience of use and precise, but expensive. 
Traditional RT-PCR uses gel electrophoresis for the detection of PCR amplification at 
end-point of the PCR reaction. This end-point detection has some problems such as low 
resolution, poor precision, low sensitivity and the need for post PCR processing. Real-time RT-
PCR allows for the detection of PCR product during the early exponential growth phases of the 
reaction. This ability of measuring the reaction kinetics in the early phases of PCR provides a 
distinct advantage over traditional PCR detection. Glo1 was not confirmed in the traditional 
RT-PCR, however, it was validated in the real-time RT-PCR, also in Northern blot analysis and 
in situ hybridization. It could be concluded that real-time RT-PCR is more sensitive than the 
traditional RT-PCR. 
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5.2.4.1 Transthyretin (TTR) 
From data analysis I, transthyretin (TTR) was the first candidate to be investigated. The 
differential effect of HF feeding in the two mouse trains clearly showed in the filter image 
inspection, and was then confirmed by Northern blot analysis loaded with the same RNA as in 
the probe synthesis for the filter hybridization. The consistent result of the array and Northern 
blot analysis supports the view that array technology is a very powerful tool for gene expression 
profiling.  
However, the expression of TTR showed a pronounced individual variation in the Northern blot 
(Fig. 4.12) loaded with different new RNA samples. To further investigate this finding, in situ 
hybridization was carried out using radioactive labelled TTR probe and mouse brain sections. 
The result demonstrates that TTR was not located in the hypothalamus but in the lateral 
ventricle and dorsal 3rd ventricle. The localization of TTR has been studied by many 
researchers. Dickson et al. isolated TTR RNA from choroid plexus of brain (Dickson et al., 
1985), using in situ hybridization Stauder et al. reported that TTR mRNA was located in 
choroid plexus epithelial cells of ventricles (Stauder et al., 1986), Kuchler-Bopp et al. showed 
that only choroidal epithelial cells in the brain synthesized TTR (Kuchler-Bopp et al., 1998), 
Saraiva reviewed the synthesis of TTR by choroids plexus and liver (Saraiva, 2002). 
It is therefore very likely that the apparent difference in TTR expression between strains 
represents a methodological artifact which results from differential dissection of hypothalami in 
individual mice. Fresh brains are soft, they need to be dissected rapidly to prevent RNA from 
degrading, and the hypothalamic boundaries are not easy to define. In this study, hypothalami 
were dissected according to a fixed protocol, and then adjusted by weighing (20-25 
g/hypothalamus), which in the case of TTR was obviously not sufficient to uniformly eliminate 
adjacent regions which express this extra-hypothalamic transcript from all samples. The 
localization of hypothalamus, lateral ventricle and dorsal 3rd ventricle is shown in Figure 5.2.  
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Figure 5.2 Image of brain section showing the localization of hypothalamus (Hypo.), dorsal 3rd 
ventricle (D3V) and lateral ventricle (LV).  
 
To overcome the “contamination”, all of the RNA samples isolated from hypothalami were 
loaded onto Northern blot and then screened by radioactive labelled TTR to select negatives for 
the second set of RNA pool for further experiments – filter and chip hybridizations. 
 
5.2.4.2 Hemoglobin alpha, adult chain 1 (Hba-α1) 
Hemoglobin alpha, adult chain 1 (Hba-α1) is located on mouse chromosome 11 (human 
chromosome 16p13.3). 
The protein consists of an iron-containing heme moiety, the prosthetic group that mediates 
reversible binding of oxygen by hemoglobin, and a tetramer of two unlike pairs, α and β, of 
globin peptide chains surrounding and protecting the heme molecule. The function of 
hemoglobin is to carry oxygen in arterial erythrocytes from the lung to peripheral tissues.  The 
distribution of Hba-α1 in brain is not only in hypothalamus but also in other areas, even all over 
the brain (Figure 4.17). Hemoglobin is synthesized in the bone marrow and expressed in the 
liver and blood (www.jax.org). It is surprising to find hemoglobin expressed in the brain. To 
check the similarity between hemoglobin and neuroglobin (mainly expressed in the brain) gene 
sequences, alignment analysis was carried out and it showed no significant similarity. Brain 
consumes 25% of total oxygen supplied by the body so that it is not surprising that Hba-α1 is 
D3V
LV LV 
Hypo.
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widely expressed in this tissue.  In this study, overall the expression of Hba-α1 was higher in 
SWR/J compared to AKR/J mice. This difference between strains may be related to the fact that 
SWR/J mice have higher metabolic rate. So far, no direct relationship between Hba-α1 
expression and obesity has been suggested. 
 
5.2.4.3 Glyoxalase I  
Glyoxalase I (Glo 1) (mouse chromosome 17) was the second candidate to be differentially 
expressed between the two inbred mouse strains. Although it was not diet induced gene in this 
study, it was assigned to the human obesity gene map (www.obesitygene.pbrc.edu human 
chromosome 6 (6p21.2)).  
The glyoxalase system, catalysing the conversion of toxic endogenously produced 2-
oxoaldehydes, such as methylglyoxal (MG) into D-lactate via the intermediate S-D-
lactoyglutathione, is composed of two enzymes: lactoylglutathione lyase (glyoxalase I, Glo 1) 
and hydroxyacylglutathione hydrolase (glyoxalase II, Glo 2) with glutathione (GSH) as the 
cofactor.  
It has been suggested that the aberrant expression of the glyoxalase system is related to cancer 
and diabetes. Ranganathan and Tew showed an elevation in glyoxalase I activity in 16 out of 21 
colon tumors compared to corresponding normal colon tissues (Ranganathan & Tew, 1993). 
Another study by Di Ilio et al. (Di Ilio et al., 1995) measured glyoxalase I and glyoxalase II 
activities in urogenital tumor and non-tumor tissues and found decreased glyoxalase I levels in 
10 out of 15 kidney tumors compared to corresponding normal kidney tissues. Elevated levels 
of glyoxalase I were also reported in human prostate cancer (Davidson et al., 1999). This 
system also appeared to be linked to complications involved in clinical diabetes mellitus as a 
result of increased levels of MG, and affected patients had higher levels of glyoxalase I and 
glyoxalase II than normal ones (Ratliff et al., 1996). Concentrations of methylglyoxal, S-D 
lactoyl glutathione and D-lactate were found to be elevated in the blood samples of both 
insulin-dependent and -independent diabetic patients, compared to normal healthy controls 
(Thornalley et al., 1989;McLellan et al., 1993). 
In this study, glyoxalase I was found total expressed at higher levels in AKR/J than in SWR/J 
mice. Higher levels of Glo1 expression in the brain has previously been reported for AKR/J 
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mice, but also BALB/cByJ, C3H/HeJ and A/J mice (Tafti et al., 2003). All of these strains are 
widely used in cancer research because of their special genetic background ( www.jax.org), for 
instance, AKR/J mice are prone to leukaemia (Myers et al., 1970;Nemirovsky & Trainin, 
1973), C3H/HeJ has poor immune response to endotoxic lipopolysaccharide due to a B-cell 
deficit (Rosenstreich & Glode, 1975;Coutinho, 1976), A/J is a model for lung tumor research 
(Festing & Blackmore, 1971;Poirier et al., 1975). Interestingly, not only AKR/J, but also 
C3H/HeJ and A/J are also models for research on diet induced obesity (DIO). This suggests that 
Glo1 may be related to obesity.  
One possible explanation for the observed strain difference in Glo1 gene expression would be 
that certain essential transcription factor binding sites (response elements) are mutated in the 
Glo1 gene of SWR/J mice. Kathrin Reichwald (IMB, Jena) has resequenced the Glo1 gene in 
order to test this idea, which revealed several sequence variations in non-coding and coding 
regions (Table 4.10). Our analysis identified several sites in the 5’ upstream region, in the 
intron 1, 5 and exon 3, which may exhibit altered binding properties for transcription factors. 
The functional significance of these sequence variations for Glo1 gene transcription will be 
tested in future experiments by reporter gene assays. 
 
5.2.4.4 Tumor necrosis factor alpha-induced protein 1 (endothelial) (TNFAIP1) 
TNFAIP1 was upregulated by high fat diet in AKR/J mice but not in SWR/J mice, which was 
shown in filter array and Northern blot but not in real-time RT-PCR and in situ hybridization. 
In the in situ hybridization, although it showed 1.6 fold upregulation in the ARC by high fat 
diet, this difference was not significant because of the individual variation, further experiment 
with more samples should be carried out to confirm this conclusion. The map location of 
TNFAIP1 is on mouse chromosome 11 (45.10 cM) and human 17q22-q23. TNFAIP1 was first 
characterized by Wolf et al. as a novel cDNA by differential screening of a tumor necrosis 
factor-alpha (TNFα) induced human umbilical vein endothelial cell library (Wolf et al., 1992). 
The intron/exon structure of TNFAIP1 was reported in 1998 by Stift et al. (Swift et al., 1998). 
The protein functions in potassium ion transport by protein binding and voltage-gated 
potassium channel activity adjustment (www.niaid.nih.gov). Because it is a newly assigned 
gene not much information on its pathological relevance is available. In 2003, Link et al. 
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reported TNFAIP1 was increased in Alzheimer’s disease brains (Link et al., 2003). So far, there 
have been no papers linking TNFAIP1 and obesity. However, many publications report on a 
role of TNFα in obesity.  
TNFα is located on mouse chromosome 17 (19.06cM) and human chromosome 6p21.3. 
Adipocytes secrete TNFα – a multifunctional proinflammatory cytokine with effects on lipid 
metabolism, coagulation, insulin resistance, and endothelial function. It was assigned to the 
human obesity gene map (www.obesitygene.pbrc.edu). Gene expression studies by Hotamisligil 
et al. showed that TNFα may induce insulin resistance in peripheral tissues both in rodent 
models of obesity and in people with obesity and diabetes (Hotamisligil et al., 
1993;Hotamisligil et al., 1995;Zinman et al., 1999). Using mice lacking TNFα function, Uysal 
et al. reported that TNFα was an important mediator of insulin resistance in obesity through its 
effects on several important sites of insulin action (Uysal et al., 1997). The role of TNFα in the 
state of insulin resistance associated with obesity was to interfere with phosphorylation of 
insulin receptor substrate 1 (IRS-1) (Hotamisligil et al., 1994a;Hotamisligil et al., 
1994b;Peraldi et al., 1996) via stimulation of p55 TNF receptor (Peraldi et al., 1996;Uysal et 
al., 1998). Moreover, TNFα was reported to be involved in the regulation of plasma leptin 
concentration in obese subjects (Corica et al., 1999). The long term effect of TNFα on 
adipocytes is inhibition of leptin synthesis and release (Fawcett et al., 2000;Medina et al., 
1999), whereas its short term effect is stimulation of leptin release (Finck et al., 
1998;Kirchgessner et al., 1997). Herrmann et al. in a promoter polymorphism study showed 
that the carriers of TNFα/-308A allele were more frequently obese than the non-carriers 
(Herrmann et al., 1998). It is followed by other evidences for the association between the 
TNFα/-308A polymorphism and obesity, with high rates of glucose oxidation in normal weight 
subjects and with lipid storage in overweight subjects (Pihlajamaki et al., 2003), with excessive 
fat accumulation (Hoffstedt et al., 2000), with the development of insulin resistance (Dalziel et 
al., 2002) and higher BMI (Brand et al., 2001). 
It is believed that TNFα has an effect on body weight regulation and that it acts probably 
through a local action on adipose tissue. Possibly, elevated secretion of TNFα from adipocytes 
in obese subjects leads to induction of TNFAIP1 in the hypothalamus. Further research needs to 
be conducted to elucidate the function of TNFAIP1 in the brain.  
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7 Abbreviations 
AA  acetic anhydride 
AgRP  agouti-related peptide 
ARC  arcuate nucleus 
BAT  brown adipose tissue 
BMI  body mass index 
BSA  bovine serum albumin 
CART  cocaine- and amphetamine-regulated transcript 
CRH  corticotropin-releasing hormone 
DEPC  diethyl pyrocarbonate 
DTT  dithiothreitol 
EDTA  ethylene diaminetetraacetic acid 
EST   expressed sequence tag 
Glo1  glyoxalase I 
Hba- α1 hemoglobin alpha, adult chain 1 
ICV  intracerebroventricular 
IPTG  isopropyl-β-D-thiogalactopyranoside 
isBAT  inter scapular brown adipose tissue 
ISH  in situ hybridization 
IVT  In Vitro transcription 
iWAT  inguinal white adipose tissue 
LEPR   leptin receptor 
LHA  lateral hypothalamic nucleus 
MC4R  melanocortin-4 receptor 
MOPS  3-(N-morpholino) propane sulfonic acid 
NPY  neuropeptide Y 
ORX  orexin 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
PFA  paraformaldehyde 
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PF-A  perifornical area 
POMC  proopiomelanocortin 
Ppp2cb  protein phosphatase 2a, catalytic subunit, beta isoform 
PVN  paraventricular hypothalamic nucleus 
rpWAT retroperitoneal white adipose tissue 
SDS  sodium-dodecyl-sulphate 
SSC  standard sodium citrate 
TAE  Tris-acetate-EDTA 
TE  Tris-EDTA 
TEA  triethanolamine 
TNFAIP1 tumor necrosis factor alpha-induced protein 1 (endothelial) 
TRH  thyrotropin-releasing hormone 
TTR  transthyretin 
VMH  ventromedial hypothalamic nucleus 
WAT  white adipose tissue  
X-Gal  5’-Bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
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8 Appendix  
8.1 Appendix 1 
Appendix 1. List of candidate genes in the inter strain comparison – AKR/J control vs. SWR/J 
control from data analysis I. 
RZPD clone ID GenBank 
accession number 
Cluster description by RZPD Fold 
changea 
IMAGp952I058 w61435 paternally expressed gene 3 3.44 
IMAGp952B1239 aa444730 small inducible cytokine A19 -3.17 
IMAGp952O0350 aa672630,ai551192  -3.13 
IMAGp952N0950 aa672655 ESTs, Highly similar to hGCN5 
[H.sapiens] 
3.03 
IMAGp952M0615 aa016919  -2.93 
IMAGp952C2060 aa981499  -2.84 
IMAGp952H1814 aa013674  -2.80 
IMAGp952B2215 aa023039  -2.73 
IMAGp952P0414 aa013706 ESTs, Moderately similar to 
dJ622L5.8.1 [H.sapiens] 
-2.72 
IMAGp952B0414 aa013524 ESTs, Weakly similar to F52C12.2 
[C.elegans] 
-2.72 
IMAGp952B0745 aa538202 ESTs, Weakly similar to putative 
RNA helicase [M.musculus] 
-2.69 
IMAGp952E0715 aa034643 ESTs, Weakly similar to 
HYPOTHETICAL 55.1 KD 
PROTEIN IN FAB1-PES4 
INTERGENIC REGION 
[Saccharomyces cerevisiae] 
-2.64 
IMAGp952L0515 aa017937 cleavage and polyadenylation specific 
factor 4, 30kD subunit 
-2.64 
IMAGp952H092 w42169 prostaglandin D2 synthase (21 kDa, 
brain) 
2.63 
IMAGp952M0260 aa982515 midline 2 -2.60 
IMAGp952L1462 aa199543,ai592642,
ai666665 
ESTs, Moderately similar to 
ZIC4_MOUSE ZINC FINGER 
PROTEIN ZIC4 [M.musculus] 
-2.59 
IMAGp952G1162 aa138161  -2.58 
IMAGp952N2214 aa013529 ESTs, Moderately similar to unnamed 
protein product [H.sapiens] 
-2.54 
IMAGp952D1420 aa061740,ai327007,
ai893662 
ESTs, Highly  similar to 
PROTEOLIPID PROTEIN PPA1 
[Saccharomyces cerevisiae] 
-2.54 
IMAGp952B1215 aa023244 M.musculus ASF mRNA -2.52 
IMAGp952L1718 aa049636  -2.48 
IMAGp952A1735 aa387581  -2.47 
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IMAGp952P1054 ai119550,ai119733 hemoglobin alpha, adult chain 1 2.47 
IMAGp952A0915 aa015253  -2.46 
IMAGp952P1232 aa259445 eukaryotic translation initiation factor 
4, gamma 2 
2.46 
IMAGp952O0249 aa673382 mitogen-activated protein kinase 
kinase kinase kinase 6 
2.45 
IMAGp952D054 ai391019,ai415191,
w29683 
s17 protein 2.42 
IMAGp952A1547 aa547134,ai505917 baculoviral IAP repeat-containing 6 -2.39 
IMAGp952G1925 aa119613,ai452165  -2.36 
IMAGp952B1327 aa168903 m6a methyltransferase -2.34 
IMAGp952P039 w77193  -2.34 
IMAGp952O1610 ai413741,ai425768,
w76774 
transmembrane tryptase 2.34 
IMAGp952C1427 aa288756  -2.33 
IMAGp952K173 w08585 ESTs, Highly similar to sh3bgr protein 
[M.musculus] 
-2.33 
IMAGp952O0232 aa286155 ESTs, Highly similar to SP24_RAT 
SECRETED PHOSPHOPROTEIN 24 
[R.norvegicus] 
-2.32 
IMAGp952E074 w20733 transmembrane 4 superfamily member 
7 
2.31 
IMAGp952B1363 aa562246  -2.30 
IMAGp952L1827 aa172854  2.29 
IMAGp952K2216 aa027487 ESTs, Moderately  similar to 
HYPOTHETICAL 63.5 KD 
PROTEIN ZK353.1 IN 
CHROMOSOME III [Caenorhabditis 
elegans] 
-2.28 
IMAGp952I1416 aa027365,ai324204 connective tissue growth factor -2.28 
IMAGp952L0663 aa572284,ai507498,
ai615843 
 -2.27 
IMAGp952O2034 aa289615  2.26 
IMAGp952N1054 ai119558 fatty acid Coenzyme A ligase, long 
chain 2 
2.24 
IMAGp952I0420 aa060202 Mus musculus clone BAC126c8 
Rsp29-like protein (Rsp29) and Als 
splice variant 2 (Als) genes, partial 
cds; Als splice variant 1 (Als), TCE2 
(Tce2), NDK3-like protein (Ndk3), 
and TCE4 (Tce4) genes, complete cds; 
and TCE5 (Tce5) gene, partial cds 
2.23 
IMAGp952I0764 aa606337  2.23 
IMAGp952M2461 aa106149  2.23 
IMAGp952I0444 aa516852 ESTs, Highly  similar to S- 2.22 
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ADENOSYLMETHIONINE 
SYNTHETASE GAMMA FORM 
[Rattus norvegicus] 
IMAGp952D2017 aa036096 ESTs, Highly  similar to 
HYPOTHETICAL 25.7 KD 
PROTEIN IN MSH1-EPT1 
INTERGENIC REGION 
[Saccharomyces cerevisiae] 
-2.22 
IMAGp952O1022 aa162681 aconitase 2, mitochondrial 2.22 
IMAGp952M131 w09175  2.21 
IMAGp952M0751 aa673494 Mus musculus cAMP-dependent 
protein kinase regulatory subunit 
mRNA, complete cds 
3.88 
IMAGp952I2410 ai413755,ai425782,
w80260 
chaperonin subunit 3 (gamma) 3.67 
IMAGp952O0238 aa432889  -2.73 
IMAGp952L2062 aa184574 ESTs, Weakly similar to PDI_RAT 
PROTEIN DISULFIDE ISOMERASE 
PRECURSOR [R.norvegicus] 
2.72 
IMAGp952L0560 ai227481 programmed cell death 4 2.47 
IMAGp952G1034 aa289937,ai661641  2.42 
IMAGp952N0262 aa184521  -2.36 
IMAGp952N1221 aa117053,ai427057,
ai550228 
 -2.35 
IMAGp952P0623 aa396595 granzyme G -2.28 
IMAGp952B052 ai414418,w42098  -2.26 
a: positive means up regulated in SWR/J group while negative means down regulated 
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8.2 Appendix 2 
Appendix 2. List of candidate genes in the inter strain comparison – AKR/J HF vs. SWR/J HF 
from data analysis I. 
RZPD clone ID GenBank 
accession number 
Cluster description by RZPD Fold 
changea 
IMAGp952F2058 ai226516,ai266816 transthyretin 12.26 
IMAGp952C1431 aa048282 ESTs, Highly similar to T17338 
hypothetical protein 
DKFZp434O125.1 - human 
[H.sapiens] 
10.55 
IMAGp952F0714 aa011728 ESTs, Weakly similar to KIAA0672 
protein [H.sapiens] 
9.07 
IMAGp952J1319 aa049077 ESTs, Weakly similar to AF161429_1 
HSPC311 [H.sapiens] 
8.87 
IMAGp952N1531 aa060121 Down syndrome critical region 
homolog 2 (human) 
6.89 
IMAGp952E149 w71639 ESTs, Weakly similar to matrin 
cyclophilin [R.norvegicus] 
-5.26 
IMAGp952N0950 aa672655 ESTs, Highly similar to hGCN5 
[H.sapiens] 
3.91 
IMAGp952B0663 aa771366 ESTs, Highly similar to 
I5P1_HUMAN TYPE I INOSITOL-
1,4,5-TRISPHOSPHATE 5-
PHOSPHATASE [H.sapiens] 
3.03 
IMAGp952O2334 aa288036,ai644752,
ai661644 
ESTs, Weakly similar to nuclear 
receptor RVR [M.musculus],thyroid 
hormone receptor alpha 
-2.86 
IMAGp952I0444 aa516852 ESTs, Highly  similar to S-
ADENOSYLMETHIONINE 
SYNTHETASE GAMMA FORM 
[Rattus norvegicus] 
2.74 
IMAGp952M2461 aa106149  -2.64 
IMAGp952O1252 aa688597 ESTs, Highly  similar to KERATIN, 
TYPE II CYTOSKELETAL 4 [Homo 
sapiens] 
-2.52 
IMAGp952H1623 aa396515 DNA segment, Chr 11, ERATO Doi 
603, expressed 
2.50 
IMAGp952I058 w61435 paternally expressed gene 3 2.48 
IMAGp952O1452 aa681073,aa682096 polynucleotide kinase 3-- phosphatase 2.40 
IMAGp952A1710 w98128 low density lipoprotein receptor 
related protein 
2.39 
IMAGp952O0565 aa185650 DNA segment, Chr 18, Wayne State 
University 98, expressed 
2.37 
IMAGp952A1610 w77706 ESTs, Highly similar to scaffold -2.32 
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attachment factor B [R.norvegicus] 
IMAGp952N2361 aa087689 ESTs, Highly  similar to S-
ADENOSYLMETHIONINE 
SYNTHETASE GAMMA FORM 
[Rattus norvegicus] 
-2.32 
IMAGp952I244 w29642  -4.06 
IMAGp952O224 w29499  3.06 
IMAGp952B1828 aa267461 ESTs, Weakly similar to 
TIG1_HUMAN RETINOIC ACID 
RECEPTOR RESPONDER 
PROTEIN 1 [H.sapiens] 
-2.96 
IMAGp952A1816 aa024120 ESTs, Highly similar to KIAA0121 
protein [H.sapiens] 
-2.88 
IMAGp952M0763 aa212649  -2.64 
IMAGp952I2440 aa433525 C-terminal binding protein 2 2.48 
IMAGp952J1123 aa108026 protein tyrosine phosphatase, non-
receptor type 16 
2.41 
IMAGp952H2414 aa013792  2.35 
IMAGp952A1462 aa139332 ESTs, Moderately similar to T12506 
hypothetical protein 
DKFZp434C212.1 - human 
[H.sapiens] 
-2.33 
a: positive means up regulated in SWR/J group while negative means down regulated 
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